{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:33:59Z","timestamp":1794375239461,"version":"4.9.0"},"reference-count":513,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T00:00:00Z","timestamp":1709078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870779"],"award-info":[{"award-number":["81870779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2021JDRC0039"],"award-info":[{"award-number":["2021JDRC0039"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010822","name":"Chengdu Science and Technology Bureau","doi-asserted-by":"publisher","award":["2022-YF05-01760-SN"],"award-info":[{"award-number":["2022-YF05-01760-SN"]}],"id":[{"id":"10.13039\/501100010822","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Metabolic diseases and their complications impose health and economic burdens worldwide. Evidence from past experimental studies and clinical trials suggests our body may have the ability to remember the past metabolic environment, such as hyperglycemia or hyperlipidemia, thus leading to chronic inflammatory disorders and other diseases even after the elimination of these metabolic environments. The long-term effects of that aberrant metabolism on the body have been summarized as metabolic memory and are found to assume a crucial role in states of health and disease. Multiple molecular mechanisms collectively participate in metabolic memory management, resulting in different cellular alterations as well as tissue and organ dysfunctions, culminating in disease progression and even affecting offspring. The elucidation and expansion of the concept of metabolic memory provides more comprehensive insight into pathogenic mechanisms underlying metabolic diseases and complications and promises to be a new target in disease detection and management. Here, we retrace the history of relevant research on metabolic memory and summarize its salient characteristics. We provide a detailed discussion of the mechanisms by which metabolic memory may be involved in disease development at molecular, cellular, and organ levels, with emphasis on the impact of epigenetic modulations. Finally, we present some of the pivotal findings arguing in favor of targeting metabolic memory to develop therapeutic strategies for metabolic diseases and provide the latest reflections on the consequences of metabolic memory as well as their implications for human health and diseases.<\/jats:p>","DOI":"10.1038\/s41392-024-01755-x","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T01:02:08Z","timestamp":1709082128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":176,"title":["Metabolic memory: mechanisms and diseases"],"prefix":"10.1038","volume":"9","author":[{"given":"Hao","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuezhang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulingxiao","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Keung","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,28]]},"reference":[{"key":"1755_CR1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","volume":"8","author":"YL Wu","year":"2023","unstructured":"Wu, Y. L. et al. Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduct. Target Ther. 8, 98 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"1755_CR2","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1755_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1614362","volume":"377","author":"A Afshin","year":"2017","unstructured":"Afshin, A. et al. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med. 377, 13\u201327 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR4","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","volume":"128","author":"M Koenen","year":"2021","unstructured":"Koenen, M., Hill, M. A., Cohen, P. & Sowers, J. R. Obesity, adipose tissue and vascular dysfunction. Circ. Res. 128, 951\u2013968 (2021).","journal-title":"Circ. Res."},{"key":"1755_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15, 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1755_CR6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Sanyal, A. J. & George, J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158, 1999\u20132014.e1991 (2020).","journal-title":"Gastroenterology"},{"key":"1755_CR7","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1152\/physrev.00002.2020","volume":"101","author":"DJ Hoffman","year":"2021","unstructured":"Hoffman, D. J., Powell, T. L., Barrett, E. S. & Hardy, D. B. Developmental origins of metabolic diseases. Physiol. Rev. 101, 739\u2013795 (2021).","journal-title":"Physiol. Rev."},{"key":"1755_CR8","doi-asserted-by":"publisher","first-page":"113290","DOI":"10.1016\/j.biopha.2022.113290","volume":"153","author":"D Li","year":"2022","unstructured":"Li, D. et al. Diet-gut microbiota-epigenetics in metabolic diseases: from mechanisms to therapeutics. Biomed. Pharmacother. 153, 113290 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1755_CR9","doi-asserted-by":"publisher","first-page":"103684","DOI":"10.1016\/j.drudis.2023.103684","volume":"28","author":"UJ Pillai","year":"2023","unstructured":"Pillai, U. J., Ray, A., Maan, M. & Dutta, M. Repurposing drugs targeting metabolic diseases for cancer therapeutics. Drug Discov. Today 28, 103684 (2023).","journal-title":"Drug Discov. Today"},{"key":"1755_CR10","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman, R. R. et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577\u20131589 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR11","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.2337\/dc20-3097","volume":"44","author":"JM Lachin","year":"2021","unstructured":"Lachin, J. M. & Nathan, D. M. Understanding metabolic memory: the prolonged influence of glycemia during the diabetes control and complications trial (DCCT) on future risks of complications during the study of the epidemiology of diabetes interventions and complications (EDIC). Diabetes Care 44, 2216\u20132224 (2021).","journal-title":"Diabetes Care"},{"key":"1755_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88981-3","volume":"11","author":"L Cris\u00f3stomo","year":"2021","unstructured":"Cris\u00f3stomo, L. et al. Inheritable testicular metabolic memory of high-fat diet causes transgenerational sperm defects in mice. Sci. Rep. 11, 9444 (2021).","journal-title":"Sci. Rep."},{"key":"1755_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nrendo.2011.72","volume":"7","author":"BW Smith","year":"2011","unstructured":"Smith, B. W. & Adams, L. A. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat. Rev. Endocrinol. 7, 456\u2013465 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1755_CR14","doi-asserted-by":"crossref","unstructured":"Writing Team for the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. J. Am. Med. Assoc. 290, 2159\u20132167 (2003).","DOI":"10.1001\/jama.290.16.2159"},{"key":"1755_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrendo.2012.243","volume":"9","author":"RR Holman","year":"2013","unstructured":"Holman, R. R. Type 2 diabetes mellitus in 2012: optimal management of T2DM remains elusive. Nat. Rev. Endocrinol. 9, 67\u201368 (2013).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1755_CR16","doi-asserted-by":"publisher","first-page":"BSR20202160","DOI":"10.1042\/BSR20202160","volume":"40","author":"R Singh","year":"2020","unstructured":"Singh, R. et al. Epigenetic modification and therapeutic targets of diabetes mellitus. Biosci. Rep. 40, BSR20202160 (2020).","journal-title":"Biosci. Rep."},{"key":"1755_CR17","doi-asserted-by":"publisher","first-page":"106933","DOI":"10.1016\/j.vph.2021.106933","volume":"142","author":"S Vasishta","year":"2022","unstructured":"Vasishta, S., Umakanth, S., Adiga, P. & Joshi, M. B. Extrinsic and intrinsic factors influencing metabolic memory in type 2 diabetes. Vasc. Pharmacol. 142, 106933 (2022).","journal-title":"Vasc. Pharmacol."},{"key":"1755_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/1753-0407.12475","volume":"9","author":"SI Yamagishi","year":"2017","unstructured":"Yamagishi, S. I., Nakamura, N. & Matsui, T. Glycation and cardiovascular disease in diabetes: a perspective on the concept of metabolic memory. J. Diabetes 9, 141\u2013148 (2017).","journal-title":"J. Diabetes"},{"key":"1755_CR19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00125-007-0684-2","volume":"50","author":"MA Ihnat","year":"2007","unstructured":"Ihnat, M. A. et al. Reactive oxygen species mediate a cellular \u2018memory\u2019 of high glucose stress signalling. Diabetologia 50, 1523\u20131531 (2007).","journal-title":"Diabetologia"},{"key":"1755_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DM Nathan","year":"1993","unstructured":"Nathan, D. M. et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977\u2013986 (1993).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR21","doi-asserted-by":"publisher","first-page":"86","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00002","volume":"124","author":"DM Nathan","year":"1996","unstructured":"Nathan, D. M. The pathophysiology of diabetic complications: how much does the glucose hypothesis explain? Ann. Intern Med. 124, 86\u201389 (1996).","journal-title":"Ann. Intern Med."},{"key":"1755_CR22","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase. The DCCT Research Group. Diabetes 35, 530\u2013545 (1986)..","DOI":"10.2337\/diabetes.35.5.530"},{"key":"1755_CR23","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care 10, 1\u201319 (1987).","DOI":"10.2337\/diacare.10.1.1"},{"key":"1755_CR24","doi-asserted-by":"crossref","unstructured":"Implementation of treatment protocols in the Diabetes Control and Complications Trial. Diabetes Care 18, 361\u2013376 (1995).","DOI":"10.2337\/diacare.18.3.361"},{"key":"1755_CR25","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2337\/diab.44.8.968","volume":"44","author":"TD Control","year":"1995","unstructured":"Control, T. D. & Group, C. T. R. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44, 968\u2013983 (1995).","journal-title":"Diabetes"},{"key":"1755_CR26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2337\/diab.45.10.1289","volume":"45","author":"D Control","year":"1996","unstructured":"Control, D. & Group, C. T. R. The absence of a glycemic threshold for the development of long-term complications: the perspective of the diabetes control and complications trial. Diabetes 45, 1289\u20131298 (1996).","journal-title":"Diabetes"},{"key":"1755_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"DM Nathan","year":"2014","unstructured":"Nathan, D. M. The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37, 9\u201316 (2014).","journal-title":"Diabetes Care"},{"key":"1755_CR28","doi-asserted-by":"crossref","unstructured":"Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 22, 99\u2013111 (1999)..","DOI":"10.2337\/diacare.22.1.99"},{"key":"1755_CR29","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1056\/NEJM200002103420603","volume":"342","author":"JM Lachin","year":"2000","unstructured":"Lachin, J. M. et al. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med. 342, 381\u2013389 (2000).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR30","doi-asserted-by":"crossref","unstructured":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352, 837\u2013853 (1998).","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"1755_CR31","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJMe0807625","volume":"359","author":"J Chalmers","year":"2008","unstructured":"Chalmers, J. & Cooper, M. E. UKPDS and the legacy effect. N. Engl. J. Med. 359, 1618\u20131620 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR32","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","volume":"353","author":"P Gaede","year":"1999","unstructured":"Gaede, P., Vedel, P., Parving, H. H. & Pedersen, O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 353, 617\u2013622 (1999).","journal-title":"Lancet"},{"key":"1755_CR33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1056\/NEJMoa021778","volume":"348","author":"P Gaede","year":"2003","unstructured":"Gaede, P. et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 348, 383\u2013393 (2003).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR34","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMoa0706245","volume":"358","author":"P Gaede","year":"2008","unstructured":"Gaede, P., Lund-Andersen, H., Parving, H. H. & Pedersen, O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N. Engl. J. Med. 358, 580\u2013591 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR35","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/med.21775","volume":"41","author":"Q Lu","year":"2021","unstructured":"Lu, Q. et al. The role of long noncoding RNA in lipid, cholesterol, and glucose metabolism and treatment of obesity syndrome. Med. Res. Rev. 41, 1751\u20131774 (2021).","journal-title":"Med. Res. Rev."},{"key":"1755_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41392-022-01125-5","volume":"7","author":"Y Duan","year":"2022","unstructured":"Duan, Y. et al. Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics. Signal. Transduct. Target Ther. 7, 265 (2022).","journal-title":"Signal. Transduct. Target Ther."},{"key":"1755_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1530\/REP-19-0259","volume":"158","author":"L Cris\u00f3stomo","year":"2019","unstructured":"Cris\u00f3stomo, L. et al. A switch from high-fat to normal diet does not restore sperm quality but prevents metabolic syndrome. Reproduction 158, 377\u2013387 (2019).","journal-title":"Reproduction"},{"key":"1755_CR38","doi-asserted-by":"publisher","first-page":"E1061","DOI":"10.1152\/ajpendo.00235.2020","volume":"319","author":"L Cris\u00f3stomo","year":"2020","unstructured":"Cris\u00f3stomo, L. et al. Diet during early life defines testicular lipid content and sperm quality in adulthood. Am. J. Physiol. Endocrinol. Metab. 319, E1061\u2013e1073, (2020).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1755_CR39","doi-asserted-by":"publisher","first-page":"e2100680","DOI":"10.1002\/mnfr.202100680","volume":"66","author":"L Cris\u00f3stomo","year":"2022","unstructured":"Cris\u00f3stomo, L. et al. Inherited metabolic memory of high-fat diet impairs testicular fatty acid content and sperm parameters. Mol. Nutr. Food Res. 66, e2100680 (2022).","journal-title":"Mol. Nutr. Food Res."},{"key":"1755_CR40","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3390\/biomedicines10040909","volume":"10","author":"L Cris\u00f3stomo","year":"2022","unstructured":"Cris\u00f3stomo, L. et al. Testicular \u201cInherited Metabolic Memory\u201d of ancestral high-fat diet is associated with sperm sncRNA Content. Biomedicines 10, 909 (2022).","journal-title":"Biomedicines"},{"key":"1755_CR41","doi-asserted-by":"publisher","first-page":"10446","DOI":"10.1074\/jbc.M115.711028","volume":"291","author":"A Leung","year":"2016","unstructured":"Leung, A. et al. Persistent chromatin modifications induced by high fat diet. J. Biol. Chem. 291, 10446\u201310455 (2016).","journal-title":"J. Biol. Chem."},{"key":"1755_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-023-09557-1","volume":"24","author":"Y Inoue","year":"2023","unstructured":"Inoue, Y. et al. High-fat diet in early life triggers both reversible and persistent epigenetic changes in the medaka fish (Oryzias latipes). BMC Genomics 24, 472 (2023).","journal-title":"BMC Genomics"},{"key":"1755_CR43","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.116.023171","volume":"134","author":"M Li","year":"2016","unstructured":"Li, M. et al. Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor C-terminal binding protein-1. Circulation 134, 1105\u20131121 (2016).","journal-title":"Circulation"},{"key":"1755_CR44","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1093\/hmg\/ddt614","volume":"23","author":"CJ Watson","year":"2014","unstructured":"Watson, C. J. et al. Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype. Hum. Mol. Genet. 23, 2176\u20132188 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"1755_CR45","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.120.316443","volume":"126","author":"L Tian","year":"2020","unstructured":"Tian, L. et al. Epigenetic metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in mitochondrial metabolism promotes right ventricular fibrosis. Circ. Res. 126, 1723\u20131745 (2020).","journal-title":"Circ. Res."},{"key":"1755_CR46","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel, P. & Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26, 225\u2013239 (2007).","journal-title":"Cancer Metastasis Rev."},{"key":"1755_CR47","first-page":"5447","volume":"12","author":"GL Semenza","year":"1992","unstructured":"Semenza, G. L. & Wang, G. L. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol. Cell Biol. 12, 5447\u20135454 (1992).","journal-title":"Mol. Cell Biol."},{"key":"1755_CR48","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9440(10)64554-3","volume":"157","author":"KL Talks","year":"2000","unstructured":"Talks, K. L. et al. The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157, 411\u2013421 (2000).","journal-title":"Am. J. Pathol."},{"key":"1755_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00018-017-2684-9","volume":"75","author":"W Luo","year":"2018","unstructured":"Luo, W. & Wang, Y. Epigenetic regulators: multifunctional proteins modulating hypoxia-inducible factor-\u03b1 protein stability and activity. Cell Mol. Life Sci. 75, 1043\u20131056 (2018).","journal-title":"Cell Mol. Life Sci."},{"key":"1755_CR50","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2020.09.009","volume":"495","author":"Y Chen","year":"2020","unstructured":"Chen, Y., Liu, M., Niu, Y. & Wang, Y. Romance of the three kingdoms in hypoxia: HIFs, epigenetic regulators, and chromatin reprogramming. Cancer Lett. 495, 211\u2013223 (2020).","journal-title":"Cancer Lett."},{"key":"1755_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13045-022-01304-5","volume":"15","author":"F Zhang","year":"2022","unstructured":"Zhang, F. et al. Crosstalk among m(6)A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application. J. Hematol. Oncol. 15, 84 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"1755_CR52","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"NC Denko","year":"2008","unstructured":"Denko, N. C. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat. Rev. Cancer 8, 705\u2013713 (2008).","journal-title":"Nat. Rev. Cancer"},{"key":"1755_CR53","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10555-022-10059-x","volume":"41","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee, A., Bilecz, A. J. & Lengyel, E. The adipocyte microenvironment and cancer. Cancer Metastasis Rev. 41, 575\u2013587 (2022).","journal-title":"Cancer Metastasis Rev."},{"key":"1755_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553\u2013565 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"1755_CR55","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1038\/s41388-023-02869-2","volume":"42","author":"P Fan","year":"2023","unstructured":"Fan, P. et al. Alleviating hypoxia to improve cancer immunotherapy. Oncogene 42, 3591\u20133604 (2023).","journal-title":"Oncogene"},{"key":"1755_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.imlet.2017.06.011","volume":"190","author":"B Li","year":"2017","unstructured":"Li, B. et al. CCL2 promoter hypomethylation is associated with gout risk in Chinese Han male population. Immunol. Lett. 190, 15\u201319 (2017).","journal-title":"Immunol. Lett."},{"key":"1755_CR57","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/art.41173","volume":"72","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Differential DNA methylation of networked signaling, transcriptional, innate and adaptive immunity, and osteoclastogenesis genes and pathways in gout. Arthritis Rheumatol. 72, 802\u2013814 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"1755_CR58","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/annrheumdis-2014-206564","volume":"75","author":"TO Cri\u0219an","year":"2016","unstructured":"Cri\u0219an, T. O. et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann. Rheum. Dis. 75, 755\u2013762 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"1755_CR59","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13075-019-1834-x","volume":"21","author":"MCP Cleophas","year":"2019","unstructured":"Cleophas, M. C. P. et al. Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression. Arthritis Res. Ther. 21, 50 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"1755_CR60","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.2337\/db06-0164","volume":"55","author":"SL Li","year":"2006","unstructured":"Li, S. L. et al. Enhanced proatherogenic responses in macrophages and vascular smooth muscle cells derived from diabetic db\/db mice. Diabetes 55, 2611\u20132619 (2006).","journal-title":"Diabetes"},{"key":"1755_CR61","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1161\/ATVBAHA.111.241109","volume":"32","author":"MA Reddy","year":"2012","unstructured":"Reddy, M. A. et al. Pro-inflammatory role of microrna-200 in vascular smooth muscle cells from diabetic mice. Arterioscler Thromb. Vasc. Biol. 32, 721\u2013729 (2012).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"1755_CR62","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1073\/pnas.87.1.404","volume":"87","author":"S Roy","year":"1990","unstructured":"Roy, S., Sala, R., Cagliero, E. & Lorenzi, M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc. Natl Acad. Sci. USA 87, 404\u2013408 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR63","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2337\/diabetes.52.3.818","volume":"52","author":"RA Kowluru","year":"2003","unstructured":"Kowluru, R. A. Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52, 818\u2013823 (2003).","journal-title":"Diabetes"},{"key":"1755_CR64","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jdiacomp.2004.03.002","volume":"18","author":"RA Kowluru","year":"2004","unstructured":"Kowluru, R. A., Abbas, S. N. & Odenbach, S. Reversal of hyperglycemia and diabetic nephropathy: effect of reinstitution of good metabolic control on oxidative stress in the kidney of diabetic rats. J. Diabetes Complic. 18, 282\u2013288 (2004).","journal-title":"J. Diabetes Complic."},{"key":"1755_CR65","doi-asserted-by":"publisher","first-page":"21976","DOI":"10.1155\/2007\/21976","volume":"2007","author":"RA Kowluru","year":"2007","unstructured":"Kowluru, R. A., Kanwar, M. & Kennedy, A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp. Diabetes Res. 2007, 21976 (2007).","journal-title":"Exp. Diabetes Res."},{"key":"1755_CR66","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1084\/jem.20081188","volume":"205","author":"A El-Osta","year":"2008","unstructured":"El-Osta, A. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409\u20132417 (2008).","journal-title":"J. Exp. Med."},{"key":"1755_CR67","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2337\/db08-1666","volume":"58","author":"D Brasacchio","year":"2009","unstructured":"Brasacchio, D. et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58, 1229\u20131236 (2009).","journal-title":"Diabetes"},{"key":"1755_CR68","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2337\/db10-0133","volume":"60","author":"Q Zhong","year":"2011","unstructured":"Zhong, Q. & Kowluru, R. A. Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy. Diabetes 60, 1304\u20131313 (2011).","journal-title":"Diabetes"},{"key":"1755_CR69","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.2337\/db12-1141","volume":"62","author":"Q Zhong","year":"2013","unstructured":"Zhong, Q. & Kowluru, R. A. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy. Diabetes 62, 2559\u20132568 (2013).","journal-title":"Diabetes"},{"key":"1755_CR70","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.2337\/db05-1607","volume":"55","author":"T Yokoi","year":"2006","unstructured":"Yokoi, T. et al. Apoptosis signal-regulating kinase 1 mediates cellular senescence induced by high glucose in endothelial cells. Diabetes 55, 1660\u20131665 (2006).","journal-title":"Diabetes"},{"key":"1755_CR71","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbrc.2007.12.021","volume":"366","author":"K Ksiazek","year":"2008","unstructured":"Ksiazek, K., Passos, J. F., Olijslagers, S. & von Zglinicki, T. Mitochondrial dysfunction is a possible cause of accelerated senescence of mesothelial cells exposed to high glucose. Biochem. Biophys. Res. Commun. 366, 793\u2013799 (2008).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1755_CR72","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1089\/scd.2010.0009","volume":"19","author":"C Cramer","year":"2010","unstructured":"Cramer, C. et al. Persistent high glucose concentrations alter the regenerative potential of mesenchymal stem cells. Stem Cells Dev. 19, 1875\u20131884 (2010).","journal-title":"Stem Cells Dev."},{"key":"1755_CR73","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cellsig.2013.10.002","volume":"26","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling. Cell Signal. 26, 110\u2013121 (2014).","journal-title":"Cell Signal."},{"key":"1755_CR74","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrc2560","volume":"9","author":"T Kuilman","year":"2009","unstructured":"Kuilman, T. & Peeper, D. S. Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 9, 81\u201394 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"1755_CR75","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/MCO.0000000000000065","volume":"17","author":"Y Zhu","year":"2014","unstructured":"Zhu, Y., Armstrong, J. L., Tchkonia, T. & Kirkland, J. L. Cellular senescence and the senescent secretory phenotype in age-related chronic diseases. Curr. Opin. Clin. Nutr. Metab. Care 17, 324\u2013328 (2014).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"1755_CR76","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2337\/db14-1820","volume":"64","author":"AK Palmer","year":"2015","unstructured":"Palmer, A. K. et al. Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes 64, 2289\u20132298 (2015).","journal-title":"Diabetes"},{"key":"1755_CR77","doi-asserted-by":"publisher","first-page":"18807","DOI":"10.1074\/jbc.RA119.010648","volume":"294","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Hyperglycemia-induced inflamm-aging accelerates gingival senescence via NLRC4 phosphorylation. J. Biol. Chem. 294, 18807\u201318819 (2019).","journal-title":"J. Biol. Chem."},{"key":"1755_CR78","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4049\/jimmunol.1901348","volume":"206","author":"K Thiem","year":"2021","unstructured":"Thiem, K. et al. Hyperglycemic memory of innate immune cells promotes in vitro proinflammatory responses of human monocytes and murine macrophages. J. Immunol. 206, 807\u2013813 (2021).","journal-title":"J. Immunol."},{"key":"1755_CR79","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.brainresbull.2009.05.006","volume":"81","author":"RA Kowluru","year":"2010","unstructured":"Kowluru, R. A. & Chan, P. S. Metabolic memory in diabetes\u2014from in vitro oddity to in vivo problem: role of apoptosis. Brain Res. Bull. 81, 297\u2013302 (2010).","journal-title":"Brain Res. Bull."},{"key":"1755_CR80","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/jcb.22644","volume":"110","author":"Q Zhong","year":"2010","unstructured":"Zhong, Q. & Kowluru, R. A. Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenon. J. Cell Biochem. 110, 1306\u20131313 (2010).","journal-title":"J. Cell Biochem."},{"key":"1755_CR81","doi-asserted-by":"publisher","first-page":"808","DOI":"10.2337\/diab.36.7.808","volume":"36","author":"RL Engerman","year":"1987","unstructured":"Engerman, R. L. & Kern, T. S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 36, 808\u2013812 (1987).","journal-title":"Diabetes"},{"key":"1755_CR82","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"Patel, A. et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 358, 2560\u20132572 (2008).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR83","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129\u2013139 (2009).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR84","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00125-009-1352-5","volume":"52","author":"S Del Prato","year":"2009","unstructured":"Del Prato, S. Megatrials in type 2 diabetes. From excitement to frustration? Diabetologia 52, 1219\u20131226 (2009).","journal-title":"Diabetologia"},{"key":"1755_CR85","doi-asserted-by":"publisher","first-page":"C644","DOI":"10.1152\/ajpcell.00380.2021","volume":"324","author":"TM Newman","year":"2023","unstructured":"Newman, T. M. et al. Early-life dietary exposures mediate persistent shifts in the gut microbiome and visceral fat metabolism. Am. J. Physiol. Cell Physiol. 324, C644\u2013c657 (2023).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"1755_CR86","doi-asserted-by":"publisher","first-page":"e0209053","DOI":"10.1371\/journal.pone.0209053","volume":"13","author":"M Summerfield","year":"2018","unstructured":"Summerfield, M. et al. A long-term maternal diet transition from high-fat diet to normal fat diet during pre-pregnancy avoids adipose tissue inflammation in next generation. PLoS ONE 13, e0209053 (2018).","journal-title":"PLoS ONE"},{"key":"1755_CR87","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jnutbio.2018.09.008","volume":"62","author":"H Xu","year":"2018","unstructured":"Xu, H. et al. A long-term maternal diet intervention is necessary to avoid the obesogenic effect of maternal high-fat diet in the offspring. J. Nutr. Biochem. 62, 210\u2013220 (2018).","journal-title":"J. Nutr. Biochem."},{"key":"1755_CR88","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/ijo.2015.236","volume":"40","author":"Q Fu","year":"2016","unstructured":"Fu, Q. et al. A short-term transition from a high-fat diet to a normal-fat diet before pregnancy exacerbates female mouse offspring obesity. Int. J. Obes. 40, 564\u2013572 (2016).","journal-title":"Int. J. Obes."},{"key":"1755_CR89","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1167\/iovs.12-9732","volume":"53","author":"S Tewari","year":"2012","unstructured":"Tewari, S., Zhong, Q., Santos, J. M. & Kowluru, R. A. Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 53, 4881\u20134888 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1755_CR90","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1167\/iovs.12-10854","volume":"54","author":"Q Zhong","year":"2013","unstructured":"Zhong, Q. & Kowluru, R. A. Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation. Invest. Ophthalmol. Vis. Sci. 54, 244\u2013250 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1755_CR91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/cbf.3358","volume":"36","author":"L Magri-Tomaz","year":"2018","unstructured":"Magri-Tomaz, L. et al. Two weeks of high-fat feeding disturb lipid and cholesterol molecular markers. Cell Biochem. Funct. 36, 387\u2013393 (2018).","journal-title":"Cell Biochem. Funct."},{"key":"1755_CR92","doi-asserted-by":"publisher","first-page":"1032293","DOI":"10.3389\/fendo.2022.1032293","volume":"13","author":"JE Welles","year":"2022","unstructured":"Welles, J. E. et al. An integrative approach to assessing effects of a short-term Western diet on gene expression in rat liver. Front. Endocrinol. 13, 1032293 (2022).","journal-title":"Front. Endocrinol."},{"key":"1755_CR93","first-page":"463.e461","volume":"210","author":"MA Suter","year":"2014","unstructured":"Suter, M. A. et al. In utero exposure to a maternal high-fat diet alters the epigenetic histone code in a murine model. Am. J. Obstet. Gynecol. 210, 463.e461\u2013463.e411 (2014).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"1755_CR94","doi-asserted-by":"publisher","first-page":"e0175675","DOI":"10.1371\/journal.pone.0175675","volume":"12","author":"UD Wankhade","year":"2017","unstructured":"Wankhade, U. D. et al. Enhanced offspring predisposition to steatohepatitis with maternal high-fat diet is associated with epigenetic and microbiome alterations. PLoS ONE 12, e0175675 (2017).","journal-title":"PLoS ONE"},{"key":"1755_CR95","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00125-014-3462-y","volume":"58","author":"MA Reddy","year":"2015","unstructured":"Reddy, M. A., Zhang, E. & Natarajan, R. Epigenetic mechanisms in diabetic complications and metabolic memory. Diabetologia 58, 443\u2013455 (2015).","journal-title":"Diabetologia"},{"key":"1755_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37837-7","volume":"14","author":"KY Li","year":"2023","unstructured":"Li, K. Y. et al. DNA methylation markers for kidney function and progression of diabetic kidney disease. Nat. Commun. 14, 2543 (2023).","journal-title":"Nat. Commun."},{"key":"1755_CR97","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1681\/ASN.2010060633","volume":"21","author":"G Sun","year":"2010","unstructured":"Sun, G. et al. Epigenetic histone methylation modulates fibrotic gene expression. J. Am. Soc. Nephrol. 21, 2069\u20132080 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1755_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.diabres.2012.10.010","volume":"99","author":"ML Alvarez","year":"2013","unstructured":"Alvarez, M. L. & Distefano, J. K. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression. Diabetes Res. Clin. Pract. 99, 1\u201311 (2013).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1755_CR99","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","volume":"128","author":"T Kouzarides","year":"2007","unstructured":"Kouzarides, T. Chromatin modifications and their function. Cell 128, 693\u2013705 (2007).","journal-title":"Cell"},{"key":"1755_CR100","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1146\/annurev-genet-120417-031404","volume":"52","author":"A Bo\u0161kovi\u0107","year":"2018","unstructured":"Bo\u0161kovi\u0107, A. & Rando, O. J. Transgenerational epigenetic inheritance. Annu. Rev. Genet. 52, 21\u201341 (2018).","journal-title":"Annu. Rev. Genet."},{"key":"1755_CR101","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41581-019-0135-6","volume":"15","author":"M Kato","year":"2019","unstructured":"Kato, M. & Natarajan, R. Epigenetics and epigenomics in diabetic kidney disease and metabolic memory. Nat. Rev. Nephrol. 15, 327\u2013345 (2019).","journal-title":"Nat. Rev. Nephrol."},{"key":"1755_CR102","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11892-019-1214-6","volume":"19","author":"T Aranyi","year":"2019","unstructured":"Aranyi, T. & Susztak, K. Cytosine methylation studies in patients with diabetic kidney disease. Curr. Diab. Rep. 19, 91 (2019).","journal-title":"Curr. Diab. Rep."},{"key":"1755_CR103","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.gde.2008.07.001","volume":"18","author":"NC Whitelaw","year":"2008","unstructured":"Whitelaw, N. C. & Whitelaw, E. Transgenerational epigenetic inheritance in health and disease. Curr. Opin. Genet. Dev. 18, 273\u2013279 (2008).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"1755_CR104","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s42003-021-02316-6","volume":"4","author":"CV Breton","year":"2021","unstructured":"Breton, C. V. et al. Exploring the evidence for epigenetic regulation of environmental influences on child health across generations. Commun. Biol. 4, 769 (2021).","journal-title":"Commun. Biol."},{"key":"1755_CR105","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nrg3230","volume":"13","author":"PA Jones","year":"2012","unstructured":"Jones, P. A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484\u2013492 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"1755_CR106","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore, L. D., Le, T. & Fan, G. DNA methylation and its basic function. Neuropsychopharmacology 38, 23\u201338 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"1755_CR107","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/nbt.1685","volume":"28","author":"A Portela","year":"2010","unstructured":"Portela, A. & Esteller, M. Epigenetic modifications and human disease. Nat. Biotechnol. 28, 1057\u20131068 (2010).","journal-title":"Nat. Biotechnol."},{"key":"1755_CR108","doi-asserted-by":"publisher","first-page":"18347","DOI":"10.1074\/jbc.R110.205286","volume":"286","author":"ZX Chen","year":"2011","unstructured":"Chen, Z. X. & Riggs, A. D. DNA methylation and demethylation in mammals. J. Biol. Chem. 286, 18347\u201318353 (2011).","journal-title":"J. Biol. Chem."},{"key":"1755_CR109","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrg2045","volume":"8","author":"RL Jirtle","year":"2007","unstructured":"Jirtle, R. L. & Skinner, M. K. Environmental epigenomics and disease susceptibility. Nat. Rev. Genet. 8, 253\u2013262 (2007).","journal-title":"Nat. Rev. Genet."},{"key":"1755_CR110","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1089\/ars.2011.4381","volume":"17","author":"J Wang","year":"2012","unstructured":"Wang, J. et al. Nutrition, epigenetics, and metabolic syndrome. Antioxid. Redox Signal. 17, 282\u2013301 (2012).","journal-title":"Antioxid. Redox Signal."},{"key":"1755_CR111","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s42255-020-0231-8","volume":"2","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. DNA methylation mediates development of HbA1c-associated complications in type 1 diabetes. Nat. Metab. 2, 744\u2013762 (2020).","journal-title":"Nat. Metab."},{"key":"1755_CR112","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1182\/blood-2016-09-687822","volume":"129","author":"R Avellino","year":"2017","unstructured":"Avellino, R. & Delwel, R. Expression and regulation of C\/EBP\u03b1 in normal myelopoiesis and in malignant transformation. Blood 129, 2083\u20132091 (2017).","journal-title":"Blood"},{"key":"1755_CR113","first-page":"E3002","volume":"113","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. Epigenomic profiling reveals an association between persistence of DNA methylation and metabolic memory in the DCCT\/EDIC type 1 diabetes cohort. Proc. Natl Acad. Sci. USA 113, E3002\u2013E3011 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR114","doi-asserted-by":"publisher","first-page":"e36278","DOI":"10.1371\/journal.pone.0036278","volume":"7","author":"D Fradin","year":"2012","unstructured":"Fradin, D. et al. Association of the CpG methylation pattern of the proximal insulin gene promoter with type 1 diabetes. PLoS ONE 7, e36278 (2012).","journal-title":"PLoS ONE"},{"key":"1755_CR115","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/2251-6581-13-69","volume":"13","author":"Z Maghbooli","year":"2014","unstructured":"Maghbooli, Z. et al. Aberrant DNA methylation patterns in diabetic nephropathy. J. Diabetes Metab. Disord. 13, 69 (2014).","journal-title":"J. Diabetes Metab. Disord."},{"key":"1755_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-3-33","volume":"3","author":"CG Bell","year":"2010","unstructured":"Bell, C. G. et al. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med. Genomics 3, 33 (2010).","journal-title":"BMC Med. Genomics"},{"key":"1755_CR117","doi-asserted-by":"publisher","DOI":"10.1186\/s40659-021-00347-1","volume":"54","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y. et al. DNMT1-mediated PPAR\u03b1 methylation aggravates damage of retinal tissues in diabetic retinopathy mice. Biol. Res. 54, 25 (2021).","journal-title":"Biol. Res."},{"key":"1755_CR118","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.kint.2017.01.010","volume":"92","author":"L Zhang","year":"2017","unstructured":"Zhang, L. et al. DNA methyltransferase 1 may be a therapy target for attenuating diabetic nephropathy and podocyte injury. Kidney Int. 92, 140\u2013153 (2017).","journal-title":"Kidney Int."},{"key":"1755_CR119","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.kint.2019.02.020","volume":"96","author":"G Chen","year":"2019","unstructured":"Chen, G. et al. Aberrant DNA methylation of mTOR pathway genes promotes inflammatory activation of immune cells in diabetic kidney disease. Kidney Int. 96, 409\u2013420 (2019).","journal-title":"Kidney Int."},{"key":"1755_CR120","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.4161\/15592294.2014.967584","volume":"9","author":"LK Park","year":"2014","unstructured":"Park, L. K. et al. Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts. Epigenetics 9, 1339\u20131349 (2014).","journal-title":"Epigenetics"},{"key":"1755_CR121","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2337\/db11-0588","volume":"61","author":"AS Olsen","year":"2012","unstructured":"Olsen, A. S., Sarras, M. P. Jr., Leontovich, A. & Intine, R. V. Heritable transmission of diabetic metabolic memory in zebrafish correlates with DNA hypomethylation and aberrant gene expression. Diabetes 61, 485\u2013491 (2012).","journal-title":"Diabetes"},{"key":"1755_CR122","doi-asserted-by":"publisher","first-page":"e14614","DOI":"10.14814\/phy2.14614","volume":"8","author":"Y Wang","year":"2020","unstructured":"Wang, Y., Tar, M. T. & Davies, K. P. Hyperglycemic memory in the rat bladder detrusor is associated with a persistent hypomethylated state. Physiol. Rep. 8, e14614 (2020).","journal-title":"Physiol. Rep."},{"key":"1755_CR123","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1007\/s00018-019-03114-4","volume":"76","author":"H Kim","year":"2019","unstructured":"Kim, H. et al. Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease. Cell Mol. Life Sci. 76, 4341\u20134354 (2019).","journal-title":"Cell Mol. Life Sci."},{"key":"1755_CR124","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1161\/HYPERTENSIONAHA.116.07910","volume":"68","author":"LF Gomez-Arango","year":"2016","unstructured":"Gomez-Arango, L. F. et al. Increased systolic and diastolic blood pressure is associated with altered gut microbiota composition and butyrate production in early pregnancy. Hypertension 68, 974\u2013981 (2016).","journal-title":"Hypertension"},{"key":"1755_CR125","doi-asserted-by":"publisher","first-page":"1098881","DOI":"10.3389\/fendo.2023.1098881","volume":"14","author":"K Peng","year":"2023","unstructured":"Peng, K. et al. Butyrate and obesity: current research status and future prospect. Front. Endocrinol. 14, 1098881 (2023).","journal-title":"Front. Endocrinol."},{"key":"1755_CR126","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3390\/genes13040705","volume":"13","author":"B \u010cugalj Kern","year":"2022","unstructured":"\u010cugalj Kern, B. et al. The role of epigenetic modifications in late complications in type 1 diabetes. Genes (Basel). 13, 705 (2022).","journal-title":"Genes (Basel)."},{"key":"1755_CR127","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister, A. J. & Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 21, 381\u2013395 (2011).","journal-title":"Cell Res."},{"key":"1755_CR128","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrm3890","volume":"15","author":"P Tessarz","year":"2014","unstructured":"Tessarz, P. & Kouzarides, T. Histone core modifications regulating nucleosome structure and dynamics. Nat. Rev. Mol. Cell Biol. 15, 703\u2013708 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1755_CR129","doi-asserted-by":"publisher","first-page":"4065382","DOI":"10.1155\/2016\/4065382","volume":"2016","author":"X Li","year":"2016","unstructured":"Li, X., Li, C. & Sun, G. Histone acetylation and its modifiers in the pathogenesis of diabetic nephropathy. J. Diabetes Res. 2016, 4065382 (2016).","journal-title":"J. Diabetes Res."},{"key":"1755_CR130","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.jnutbio.2010.03.014","volume":"22","author":"JM Yun","year":"2011","unstructured":"Yun, J. M., Jialal, I. & Devaraj, S. Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J. Nutr. Biochem. 22, 450\u2013458 (2011).","journal-title":"J. Nutr. Biochem."},{"key":"1755_CR131","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2337\/db11-0416","volume":"61","author":"Z Zheng","year":"2012","unstructured":"Zheng, Z. et al. Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1\/AMPK\/ROS pathway and therapeutic effects of metformin. Diabetes 61, 217\u2013228 (2012).","journal-title":"Diabetes"},{"key":"1755_CR132","doi-asserted-by":"publisher","first-page":"111274","DOI":"10.1016\/j.biopha.2021.111274","volume":"137","author":"Y Tu","year":"2021","unstructured":"Tu, Y. et al. Melatonin attenuates oxidative stress and inflammation of M\u00fcller cells in diabetic retinopathy via activating the Sirt1 pathway. Biomed. Pharmacother. 137, 111274 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"1755_CR133","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41418-020-00631-9","volume":"28","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Histone deacetylase 3 aberration inhibits Klotho transcription and promotes renal fibrosis. Cell Death Differ. 28, 1001\u20131012 (2021).","journal-title":"Cell Death Differ."},{"key":"1755_CR134","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/ki.2014.111","volume":"86","author":"X Wang","year":"2014","unstructured":"Wang, X. et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int. 86, 712\u2013725 (2014).","journal-title":"Kidney Int."},{"key":"1755_CR135","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nrg.2016.59","volume":"17","author":"CD Allis","year":"2016","unstructured":"Allis, C. D. & Jenuwein, T. The molecular hallmarks of epigenetic control. Nat. Rev. Genet. 17, 487\u2013500 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"1755_CR136","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2337\/db17-0996","volume":"67","author":"M Mishra","year":"2018","unstructured":"Mishra, M., Duraisamy, A. J. & Kowluru, R. A. Sirt1: a guardian of the development of diabetic retinopathy. Diabetes 67, 745\u2013754 (2018).","journal-title":"Diabetes"},{"key":"1755_CR137","doi-asserted-by":"publisher","first-page":"J207","DOI":"10.1016\/j.jaut.2009.12.006","volume":"34","author":"WH Brooks","year":"2010","unstructured":"Brooks, W. H. et al. Epigenetics and autoimmunity. J. Autoimmun. 34, J207\u2013J219 (2010).","journal-title":"J. Autoimmun."},{"key":"1755_CR138","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrm2143","volume":"8","author":"RJ Klose","year":"2007","unstructured":"Klose, R. J. & Zhang, Y. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8, 307\u2013318 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1755_CR139","doi-asserted-by":"publisher","first-page":"9047","DOI":"10.1073\/pnas.0803623105","volume":"105","author":"LM Villeneuve","year":"2008","unstructured":"Villeneuve, L. M. et al. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc. Natl Acad. Sci. USA 105, 9047\u20139052 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR140","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/labinvest.2013.47","volume":"93","author":"R Komers","year":"2013","unstructured":"Komers, R. et al. Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes. Lab Invest. 93, 543\u2013552 (2013).","journal-title":"Lab Invest."},{"key":"1755_CR141","doi-asserted-by":"publisher","first-page":"12695","DOI":"10.1074\/jbc.RA119.007575","volume":"294","author":"Y Jia","year":"2019","unstructured":"Jia, Y. et al. Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-\u03b21-induced gene expression in mesangial cells and diabetic kidney. J. Biol. Chem. 294, 12695\u201312707 (2019).","journal-title":"J. Biol. Chem."},{"key":"1755_CR142","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nrg2540","volume":"10","author":"H Cedar","year":"2009","unstructured":"Cedar, H. & Bergman, Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat. Rev. Genet. 10, 295\u2013304 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"1755_CR143","doi-asserted-by":"publisher","first-page":"657","DOI":"10.2217\/epi.10.44","volume":"2","author":"H Hashimoto","year":"2010","unstructured":"Hashimoto, H., Vertino, P. M. & Cheng, X. Molecular coupling of DNA methylation and histone methylation. Epigenomics 2, 657\u2013669 (2010).","journal-title":"Epigenomics"},{"key":"1755_CR144","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1042\/BST20170574","volume":"46","author":"H Gowher","year":"2018","unstructured":"Gowher, H. & Jeltsch, A. Mammalian DNA methyltransferases: new discoveries and open questions. Biochem. Soc. Trans. 46, 1191\u20131202 (2018).","journal-title":"Biochem. Soc. Trans."},{"key":"1755_CR145","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.2337\/db18-0124","volume":"67","author":"TA Alghamdi","year":"2018","unstructured":"Alghamdi, T. A. et al. Histone H3 serine 10 phosphorylation facilitates endothelial activation in diabetic kidney disease. Diabetes 67, 2668\u20132681 (2018).","journal-title":"Diabetes"},{"key":"1755_CR146","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.jdiacomp.2015.02.011","volume":"29","author":"JJ Liu","year":"2015","unstructured":"Liu, J. J. et al. Vascular cell adhesion molecule-1, but not intercellular adhesion molecule-1, is associated with diabetic kidney disease in Asians with type 2 diabetes. J. Diabetes Complic. 29, 707\u2013712 (2015).","journal-title":"J. Diabetes Complic."},{"key":"1755_CR147","doi-asserted-by":"publisher","first-page":"e13715","DOI":"10.7717\/peerj.13715","volume":"10","author":"Z Svikle","year":"2022","unstructured":"Svikle, Z. et al. Ubiquitin-proteasome system in diabetic retinopathy. PeerJ 10, e13715 (2022).","journal-title":"PeerJ"},{"key":"1755_CR148","doi-asserted-by":"publisher","first-page":"589474","DOI":"10.1155\/2013\/589474","volume":"2013","author":"C Gao","year":"2013","unstructured":"Gao, C. et al. Impact of high glucose and proteasome inhibitor MG132 on histone H2A and H2B ubiquitination in rat glomerular mesangial cells. J. Diabetes Res. 2013, 589474 (2013).","journal-title":"J. Diabetes Res."},{"key":"1755_CR149","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang, D. et al. Metabolic regulation of gene expression by histone lactylation. Nature 574, 575\u2013580 (2019).","journal-title":"Nature"},{"key":"1755_CR150","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/path.2638","volume":"220","author":"RJ Taft","year":"2010","unstructured":"Taft, R. J. et al. Non-coding RNAs: regulators of disease. J. Pathol. 220, 126\u2013139 (2010).","journal-title":"J. Pathol."},{"key":"1755_CR151","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fgene.2015.00002","volume":"6","author":"AF Palazzo","year":"2015","unstructured":"Palazzo, A. F. & Lee, E. S. Non-coding RNA: what is functional and what is junk? Front. Genet. 6, 2 (2015).","journal-title":"Front. Genet."},{"key":"1755_CR152","doi-asserted-by":"publisher","first-page":"19886","DOI":"10.3390\/ijms160819886","volume":"16","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. Regulatory roles of non-coding RNAs in colorectal cancer. Int. J. Mol. Sci. 16, 19886\u201319919 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR153","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41580-021-00447-6","volume":"23","author":"T Nojima","year":"2022","unstructured":"Nojima, T. & Proudfoot, N. J. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat. Rev. Mol. Cell Biol. 23, 389\u2013406 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1755_CR154","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/cvr\/cvr300","volume":"93","author":"S Shantikumar","year":"2012","unstructured":"Shantikumar, S., Caporali, A. & Emanueli, C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc. Res. 93, 583\u2013593 (2012).","journal-title":"Cardiovasc. Res."},{"key":"1755_CR155","doi-asserted-by":"publisher","first-page":"e18613","DOI":"10.1371\/journal.pone.0018613","volume":"6","author":"JL Esguerra","year":"2011","unstructured":"Esguerra, J. L., Bolmeson, C., Cilio, C. M. & Eliasson, L. Differential glucose-regulation of microRNAs in pancreatic islets of non-obese type 2 diabetes model Goto-Kakizaki rat. PLoS ONE 6, e18613 (2011).","journal-title":"PLoS ONE"},{"key":"1755_CR156","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nature10112","volume":"474","author":"M Trajkovski","year":"2011","unstructured":"Trajkovski, M. et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474, 649\u2013653 (2011).","journal-title":"Nature"},{"key":"1755_CR157","doi-asserted-by":"publisher","first-page":"11837","DOI":"10.1074\/jbc.M110.194969","volume":"286","author":"J Long","year":"2011","unstructured":"Long, J. et al. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J. Biol. Chem. 286, 11837\u201311848 (2011).","journal-title":"J. Biol. Chem."},{"key":"1755_CR158","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.tem.2015.09.006","volume":"26","author":"SM Hartig","year":"2015","unstructured":"Hartig, S. M., Hamilton, M. P., Bader, D. A. & McGuire, S. E. The miRNA interactome in metabolic homeostasis. Trends Endocrinol. Metab. 26, 733\u2013745 (2015).","journal-title":"Trends Endocrinol. Metab."},{"key":"1755_CR159","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41580-021-00354-w","volume":"22","author":"P Agbu","year":"2021","unstructured":"Agbu, P. & Carthew, R. W. MicroRNA-mediated regulation of glucose and lipid metabolism. Nat. Rev. Mol. Cell Biol. 22, 425\u2013438 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1755_CR160","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.2174\/0929867329666220801161536","volume":"30","author":"M Macvanin","year":"2023","unstructured":"Macvanin, M. et al. The role of miRNAs in metabolic diseases. Curr. Med. Chem. 30, 1922\u20131944 (2023).","journal-title":"Curr. Med. Chem."},{"key":"1755_CR161","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00125-012-2804-x","volume":"56","author":"X Zhong","year":"2013","unstructured":"Zhong, X. et al. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia 56, 663\u2013674 (2013).","journal-title":"Diabetologia"},{"key":"1755_CR162","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrneph.2014.116","volume":"10","author":"M Kato","year":"2014","unstructured":"Kato, M. & Natarajan, R. Diabetic nephropathy\u2013emerging epigenetic mechanisms. Nat. Rev. Nephrol. 10, 517\u2013530 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"1755_CR163","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nature10887","volume":"482","author":"M Guttman","year":"2012","unstructured":"Guttman, M. & Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339\u2013346 (2012).","journal-title":"Nature"},{"key":"1755_CR164","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1101\/gad.17446611","volume":"25","author":"MN Cabili","year":"2011","unstructured":"Cabili, M. N. et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25, 1915\u20131927 (2011).","journal-title":"Genes Dev."},{"key":"1755_CR165","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tibs.2015.08.002","volume":"40","author":"XY Zhao","year":"2015","unstructured":"Zhao, X. Y. & Lin, J. D. Long noncoding RNAs: a new regulatory code in metabolic control. Trends Biochem. Sci. 40, 586\u2013596 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"1755_CR166","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","volume":"73","author":"SU Schmitz","year":"2016","unstructured":"Schmitz, S. U., Grote, P. & Herrmann, B. G. Mechanisms of long noncoding RNA function in development and disease. Cell Mol. Life Sci. 73, 2491\u20132509 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"1755_CR167","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1167\/iovs.16-20569","volume":"58","author":"AA Thomas","year":"2017","unstructured":"Thomas, A. A., Feng, B. & Chakrabarti, S. ANRIL: a regulator of VEGF in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 58, 470\u2013480 (2017).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1755_CR168","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canlet.2017.03.040","volume":"407","author":"ME Forrest","year":"2017","unstructured":"Forrest, M. E. & Khalil, A. M. Review: regulation of the cancer epigenome by long non-coding RNAs. Cancer Lett. 407, 106\u2013112 (2017).","journal-title":"Cancer Lett."},{"key":"1755_CR169","doi-asserted-by":"publisher","first-page":"215798","DOI":"10.1016\/j.canlet.2022.215798","volume":"543","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling. Cancer Lett. 543, 215798 (2022).","journal-title":"Cancer Lett."},{"key":"1755_CR170","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s00018-018-2760-9","volume":"75","author":"N Goyal","year":"2018","unstructured":"Goyal, N., Kesharwani, D. & Datta, M. Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs. Cell Mol. Life Sci. 75, 1827\u20131837 (2018).","journal-title":"Cell Mol. Life Sci."},{"key":"1755_CR171","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.bbrc.2016.01.164","volume":"471","author":"GZ Qiu","year":"2016","unstructured":"Qiu, G. Z. et al. Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction. Biochem. Biophys. Res. Commun. 471, 135\u2013141 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1755_CR172","doi-asserted-by":"publisher","first-page":"E598","DOI":"10.1152\/ajpendo.00089.2020","volume":"320","author":"Y He","year":"2021","unstructured":"He, Y. et al. DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K\/Akt\/mTOR signaling pathway. Am. J. Physiol. Endocrinol. Metab. 320, E598\u2013e608, (2021).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1755_CR173","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1007\/s00125-015-3600-1","volume":"58","author":"ND Russell","year":"2015","unstructured":"Russell, N. D. & Cooper, M. E. 50 years forward: mechanisms of hyperglycaemia-driven diabetic complications. Diabetologia 58, 1708\u20131714 (2015).","journal-title":"Diabetologia"},{"key":"1755_CR174","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/414813a","volume":"414","author":"M Brownlee","year":"2001","unstructured":"Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813\u2013820 (2001).","journal-title":"Nature"},{"key":"1755_CR175","doi-asserted-by":"publisher","first-page":"11409","DOI":"10.1016\/S0021-9258(19)38410-8","volume":"265","author":"BL Trumpower","year":"1990","unstructured":"Trumpower, B. L. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J. Biol. Chem. 265, 11409\u201311412 (1990).","journal-title":"J. Biol. Chem."},{"key":"1755_CR176","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1161\/01.CIR.0000091257.27563.32","volume":"108","author":"MA Creager","year":"2003","unstructured":"Creager, M. A., L\u00fcscher, T. F., Cosentino, F. & Beckman, J. A. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation 108, 1527\u20131532 (2003).","journal-title":"Circulation"},{"key":"1755_CR177","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2337\/diabetes.48.4.855","volume":"48","author":"KK Yerneni","year":"1999","unstructured":"Yerneni, K. K. et al. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 48, 855\u2013864 (1999).","journal-title":"Diabetes"},{"key":"1755_CR178","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","volume":"49","author":"T Inoguchi","year":"2000","unstructured":"Inoguchi, T. et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C\u2013dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49, 1939\u20131945 (2000).","journal-title":"Diabetes"},{"key":"1755_CR179","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","volume":"106","author":"P Geraldes","year":"2010","unstructured":"Geraldes, P. & King, G. L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 106, 1319\u20131331 (2010).","journal-title":"Circ. Res."},{"key":"1755_CR180","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1007\/s00018-004-4220-y","volume":"61","author":"F Foury","year":"2004","unstructured":"Foury, F., Hu, J. & Vanderstraeten, S. Mitochondrial DNA mutators. Cell Mol. Life Sci. 61, 2799\u20132811 (2004).","journal-title":"Cell Mol. Life Sci."},{"key":"1755_CR181","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s11883-010-0128-1","volume":"12","author":"P Murray","year":"2010","unstructured":"Murray, P., Chune, G. W. & Raghavan, V. A. Legacy effects from DCCT and UKPDS: what they mean and implications for future diabetes trials. Curr. Atheroscler. Rep. 12, 432\u2013439 (2010).","journal-title":"Curr. Atheroscler. Rep."},{"key":"1755_CR182","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00592-004-0165-8","volume":"41","author":"RA Kowluru","year":"2004","unstructured":"Kowluru, R. A., Chakrabarti, S. & Chen, S. Re-institution of good metabolic control in diabetic rats and activation of caspase-3 and nuclear transcriptional factor (NF-kappaB) in the retina. Acta Diabetol. 41, 194\u2013199 (2004).","journal-title":"Acta Diabetol."},{"key":"1755_CR183","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.cccn.2004.12.005","volume":"355","author":"S Savitha","year":"2005","unstructured":"Savitha, S., Tamilselvan, J., Anusuyadevi, M. & Panneerselvam, C. Oxidative stress on mitochondrial antioxidant defense system in the aging process: role of DL-alpha-lipoic acid and L-carnitine. Clin. Chim. Acta 355, 173\u2013180 (2005).","journal-title":"Clin. Chim. Acta"},{"key":"1755_CR184","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615\u20131625 (2005).","journal-title":"Diabetes"},{"key":"1755_CR185","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 107, 1058\u20131070 (2010).","journal-title":"Circ. Res."},{"key":"1755_CR186","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s001250051591","volume":"44","author":"R Singh","year":"2001","unstructured":"Singh, R., Barden, A., Mori, T. & Beilin, L. Advanced glycation end-products: a review. Diabetologia 44, 129\u2013146 (2001).","journal-title":"Diabetologia"},{"key":"1755_CR187","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.3390\/nu13082802","volume":"13","author":"ME Garay-Sevilla","year":"2021","unstructured":"Garay-Sevilla, M. E., Rojas, A., Portero-Otin, M. & Uribarri, J. Dietary AGEs as exogenous boosters of inflammation. Nutrients 13, 2802 (2021).","journal-title":"Nutrients"},{"key":"1755_CR188","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10719-016-9694-y","volume":"33","author":"C Henning","year":"2016","unstructured":"Henning, C. & Glomb, M. A. Pathways of the Maillard reaction under physiological conditions. Glycoconj. J. 33, 499\u2013512 (2016).","journal-title":"Glycoconj. J."},{"key":"1755_CR189","doi-asserted-by":"publisher","first-page":"B105","DOI":"10.1093\/geronj\/45.4.B105","volume":"45","author":"VM Monnier","year":"1990","unstructured":"Monnier, V. M. Nonenzymatic glycosylation, the Maillard reaction and the aging process. J. Gerontol. 45, B105\u2013111, (1990).","journal-title":"J. Gerontol."},{"issue":"Suppl 3","key":"1755_CR190","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.2337\/diab.45.3.S65","volume":"45","author":"H Vlassara","year":"1996","unstructured":"Vlassara, H. & Bucala, R. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors. Diabetes 45(Suppl 3), S65\u2013S66 (1996).","journal-title":"Diabetes"},{"key":"1755_CR191","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.semnephrol.2007.01.006","volume":"27","author":"AL Tan","year":"2007","unstructured":"Tan, A. L., Forbes, J. M. & Cooper, M. E. AGE, RAGE, and ROS in diabetic nephropathy. Semin. Nephrol. 27, 130\u2013143 (2007).","journal-title":"Semin. Nephrol."},{"key":"1755_CR192","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.exger.2010.11.007","volume":"46","author":"S Yamagishi","year":"2011","unstructured":"Yamagishi, S. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp. Gerontol. 46, 217\u2013224 (2011).","journal-title":"Exp. Gerontol."},{"key":"1755_CR193","doi-asserted-by":"publisher","first-page":"969","DOI":"10.2174\/138161208784139701","volume":"14","author":"H Hyogo","year":"2008","unstructured":"Hyogo, H. & Yamagishi, S. Advanced glycation end products (AGEs) and their involvement in liver disease. Curr. Pharm. Des. 14, 969\u2013972 (2008).","journal-title":"Curr. Pharm. Des."},{"key":"1755_CR194","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-015-0090-z","volume":"20","author":"S Yamagishi","year":"2015","unstructured":"Yamagishi, S. & Matsui, T. Role of receptor for advanced glycation end products (RAGE) in liver disease. Eur. J. Med. Res. 20, 15 (2015).","journal-title":"Eur. J. Med. Res."},{"key":"1755_CR195","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1515\/cclm-2012-0832","volume":"52","author":"S Arsov","year":"2014","unstructured":"Arsov, S. et al. Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review. Clin. Chem. Lab Med. 52, 11\u201320 (2014).","journal-title":"Clin. Chem. Lab Med."},{"key":"1755_CR196","doi-asserted-by":"publisher","first-page":"266","DOI":"10.2337\/db14-0215","volume":"64","author":"S Genuth","year":"2015","unstructured":"Genuth, S. et al. Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes. Diabetes 64, 266\u2013278 (2015).","journal-title":"Diabetes"},{"key":"1755_CR197","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1161\/ATVBAHA.113.302731","volume":"34","author":"LC de Vos","year":"2014","unstructured":"de Vos, L. C. et al. Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler. Thromb. Vasc. Biol. 34, 933\u2013938 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1755_CR198","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","volume":"318","author":"M Brownlee","year":"1988","unstructured":"Brownlee, M., Cerami, A. & Vlassara, H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N. Engl. J. Med. 318, 1315\u20131321 (1988).","journal-title":"N. Engl. J. Med."},{"key":"1755_CR199","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin, A., Beckman, J. A., Schmidt, A. M. & Creager, M. A. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation 114, 597\u2013605 (2006).","journal-title":"Circulation"},{"key":"1755_CR200","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0047-6374(01)00225-1","volume":"122","author":"AJ Bailey","year":"2001","unstructured":"Bailey, A. J. Molecular mechanisms of ageing in connective tissues. Mech. Ageing Dev. 122, 735\u2013755 (2001).","journal-title":"Mech. Ageing Dev."},{"key":"1755_CR201","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00004872-200301000-00002","volume":"21","author":"D Aronson","year":"2003","unstructured":"Aronson, D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J. Hypertens. 21, 3\u201312 (2003).","journal-title":"J. Hypertens."},{"key":"1755_CR202","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10020-018-0060-3","volume":"24","author":"SL Fishman","year":"2018","unstructured":"Fishman, S. L. et al. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol. Med. 24, 59 (2018).","journal-title":"Mol. Med."},{"key":"1755_CR203","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1161\/01.ATV.18.7.1140","volume":"18","author":"J Zhang","year":"1998","unstructured":"Zhang, J., Ren, S., Sun, D. & Shen, G. X. Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells. Arterioscler Thromb. Vasc. Biol. 18, 1140\u20131148 (1998).","journal-title":"Arterioscler Thromb. Vasc. Biol."},{"key":"1755_CR204","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/molecules21020143","volume":"21","author":"F Bahmani","year":"2016","unstructured":"Bahmani, F., Bathaie, S. Z., Aldavood, S. J. & Ghahghaei, A. Inhibitory effect of crocin(s) on lens \u03b1-crystallin glycation and aggregation, results in the decrease of the risk of diabetic cataract. Molecules 21, 143 (2016).","journal-title":"Molecules"},{"key":"1755_CR205","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.numecd.2008.06.006","volume":"18","author":"G Pugliese","year":"2008","unstructured":"Pugliese, G. Do advanced glycation end products contribute to the development of long-term diabetic complications? Nutr. Metab. Cardiovasc Dis. 18, 457\u2013460 (2008).","journal-title":"Nutr. Metab. Cardiovasc Dis."},{"key":"1755_CR206","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1111\/febs.12170","volume":"280","author":"S Yamabe","year":"2013","unstructured":"Yamabe, S. et al. Intracellular accumulation of advanced glycation end products induces apoptosis via endoplasmic reticulum stress in chondrocytes. FEBS J. 280, 1617\u20131629 (2013).","journal-title":"FEBS J."},{"key":"1755_CR207","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1002\/jbmr.4053","volume":"35","author":"R Suzuki","year":"2020","unstructured":"Suzuki, R. et al. Intracellular accumulation of advanced glycation end products induces osteoblast apoptosis via endoplasmic reticulum stress. J. Bone Min. Res. 35, 1992\u20132003 (2020).","journal-title":"J. Bone Min. Res."},{"key":"1755_CR208","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1515\/cclm-2012-0826","volume":"52","author":"C Adamopoulos","year":"2014","unstructured":"Adamopoulos, C. et al. Advanced glycation end-products induce endoplasmic reticulum stress in human aortic endothelial cells. Clin. Chem. Lab Med. 52, 151\u2013160 (2014).","journal-title":"Clin. Chem. Lab Med."},{"key":"1755_CR209","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/ncb0311-184","volume":"13","author":"I Tabas","year":"2011","unstructured":"Tabas, I. & Ron, D. Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat. Cell Biol. 13, 184\u2013190 (2011).","journal-title":"Nat. Cell Biol."},{"key":"1755_CR210","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3233\/JAD-191236","volume":"76","author":"F Akhter","year":"2020","unstructured":"Akhter, F. et al. High dietary advanced glycation end products impair mitochondrial and cognitive function. J. Alzheimers Dis. 76, 165\u2013178 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"1755_CR211","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.freeradbiomed.2020.12.021","volume":"164","author":"F Akhter","year":"2021","unstructured":"Akhter, F. et al. Age-dependent accumulation of dicarbonyls and advanced glycation endproducts (AGEs) associates with mitochondrial stress. Free Radic. Biol. Med. 164, 429\u2013438 (2021).","journal-title":"Free Radic. Biol. Med."},{"key":"1755_CR212","doi-asserted-by":"publisher","first-page":"16r","DOI":"10.1093\/glycob\/cwi053","volume":"15","author":"R Ramasamy","year":"2005","unstructured":"Ramasamy, R. et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15, 16r\u201328r (2005).","journal-title":"Glycobiology"},{"key":"1755_CR213","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/modpathol.3800661","volume":"19","author":"P Morbini","year":"2006","unstructured":"Morbini, P. et al. The receptor for advanced glycation end products and its ligands: a new inflammatory pathway in lung disease? Mod. Pathol. 19, 1437\u20131445 (2006).","journal-title":"Mod. Pathol."},{"key":"1755_CR214","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.tibs.2011.08.008","volume":"36","author":"G Fritz","year":"2011","unstructured":"Fritz, G. RAGE: a single receptor fits multiple ligands. Trends Biochem. Sci. 36, 625\u2013632 (2011).","journal-title":"Trends Biochem. Sci."},{"key":"1755_CR215","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1146\/annurev-med-041316-085215","volume":"69","author":"BI Hudson","year":"2018","unstructured":"Hudson, B. I. & Lippman, M. E. Targeting RAGE signaling in inflammatory disease. Annu. Rev. Med. 69, 349\u2013364 (2018).","journal-title":"Annu. Rev. Med."},{"key":"1755_CR216","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1172\/JCI200114002","volume":"108","author":"AM Schmidt","year":"2001","unstructured":"Schmidt, A. M., Yan, S. D., Yan, S. F. & Stern, D. M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Invest. 108, 949\u2013955 (2001).","journal-title":"J. Clin. Invest."},{"key":"1755_CR217","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.tcm.2005.08.003","volume":"15","author":"R Ramasamy","year":"2005","unstructured":"Ramasamy, R., Yan, S. F. & Schmidt, A. M. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc. Med. 15, 237\u2013243 (2005).","journal-title":"Trends Cardiovasc. Med."},{"key":"1755_CR218","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1515\/bmc-2016-0021","volume":"7","author":"A Kumar Pasupulati","year":"2016","unstructured":"Kumar Pasupulati, A., Chitra, P. S. & Reddy, G. B. Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy. Biomol. Concepts 7, 293\u2013309 (2016).","journal-title":"Biomol. Concepts"},{"key":"1755_CR219","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","volume":"2","author":"C Ott","year":"2014","unstructured":"Ott, C. et al. Role of advanced glycation end products in cellular signaling. Redox Biol. 2, 411\u2013429 (2014).","journal-title":"Redox Biol."},{"key":"1755_CR220","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/CRD.0b013e318244e57c","volume":"20","author":"A Prasad","year":"2012","unstructured":"Prasad, A., Bekker, P. & Tsimikas, S. Advanced glycation end products and diabetic cardiovascular disease. Cardiol. Rev. 20, 177\u2013183 (2012).","journal-title":"Cardiol. Rev."},{"key":"1755_CR221","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1517\/13543784.11.9.1205","volume":"11","author":"AW Stitt","year":"2002","unstructured":"Stitt, A. W., Jenkins, A. J. & Cooper, M. E. Advanced glycation end products and diabetic complications. Expert Opin. Investig. Drugs 11, 1205\u20131223 (2002).","journal-title":"Expert Opin. Investig. Drugs"},{"key":"1755_CR222","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/cvr\/cvr024","volume":"90","author":"MA Reddy","year":"2011","unstructured":"Reddy, M. A. & Natarajan, R. Epigenetic mechanisms in diabetic vascular complications. Cardiovasc. Res. 90, 421\u2013429 (2011).","journal-title":"Cardiovasc. Res."},{"key":"1755_CR223","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1042\/CS20120673","volume":"125","author":"JA Thompson","year":"2013","unstructured":"Thompson, J. A. & Webb, R. C. Potential role of Toll-like receptors in programming of vascular dysfunction. Clin. Sci. 125, 19\u201325 (2013).","journal-title":"Clin. Sci."},{"key":"1755_CR224","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/cvr\/cvr268","volume":"93","author":"B Schroen","year":"2012","unstructured":"Schroen, B. & Heymans, S. Small but smart\u2013microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovasc. Res. 93, 605\u2013613 (2012).","journal-title":"Cardiovasc. Res."},{"key":"1755_CR225","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000364934","volume":"40","author":"V Guarner","year":"2015","unstructured":"Guarner, V. & Rubio-Ruiz, M. E. Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. Interdiscip. Top. Gerontol. 40, 99\u2013106 (2015).","journal-title":"Interdiscip. Top. Gerontol."},{"key":"1755_CR226","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3389\/fimmu.2020.01071","volume":"11","author":"DM Mossel","year":"2020","unstructured":"Mossel, D. M. et al. Epigenetic regulation of S100A9 and S100A12 expression in monocyte-macrophage system in hyperglycemic conditions. Front Immunol. 11, 1071 (2020).","journal-title":"Front Immunol."},{"key":"1755_CR227","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.1007\/s00018-016-2316-9","volume":"73","author":"JA van Diepen","year":"2016","unstructured":"van Diepen, J. A. et al. Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive? Cell Mol. Life Sci. 73, 4675\u20134684 (2016).","journal-title":"Cell Mol. Life Sci."},{"key":"1755_CR228","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","volume":"144","author":"L Edgar","year":"2021","unstructured":"Edgar, L. et al. Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis. Circulation 144, 961\u2013982 (2021).","journal-title":"Circulation"},{"key":"1755_CR229","doi-asserted-by":"publisher","first-page":"e0132984","DOI":"10.1371\/journal.pone.0132984","volume":"10","author":"M Cabanel","year":"2015","unstructured":"Cabanel, M. et al. Epigenetic control of macrophage shape transition towards an atypical elongated phenotype by histone deacetylase activity. PLoS ONE 10, e0132984 (2015).","journal-title":"PLoS ONE"},{"key":"1755_CR230","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/eji.202048651","volume":"50","author":"FM Davis","year":"2020","unstructured":"Davis, F. M. et al. Palmitate-TLR4 signaling regulates the histone demethylase, JMJD3, in macrophages and impairs diabetic wound healing. Eur. J. Immunol. 50, 1929\u20131940 (2020).","journal-title":"Eur. J. Immunol."},{"key":"1755_CR231","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbrc.2009.07.160","volume":"388","author":"D Gao","year":"2009","unstructured":"Gao, D., Bailey, C. J. & Griffiths, H. R. Metabolic memory effect of the saturated fatty acid, palmitate, in monocytes. Biochem. Biophys. Res. Commun. 388, 278\u2013282 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl 2","key":"1755_CR232","doi-asserted-by":"publisher","first-page":"S285","DOI":"10.2337\/dc11-s239","volume":"34","author":"A Avogaro","year":"2011","unstructured":"Avogaro, A. et al. Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care 34(Suppl 2), S285\u2013S290 (2011).","journal-title":"Diabetes Care"},{"key":"1755_CR233","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1113\/JP277050","volume":"597","author":"LK Walsh","year":"2019","unstructured":"Walsh, L. K. et al. Increased endothelial shear stress improves insulin-stimulated vasodilatation in skeletal muscle. J. Physiol. 597, 57\u201369 (2019).","journal-title":"J. Physiol."},{"key":"1755_CR234","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/oby.21508","volume":"24","author":"S Dimassi","year":"2016","unstructured":"Dimassi, S. et al. Role of eNOS- and NOX-containing microparticles in endothelial dysfunction in patients with obesity. Obesity 24, 1305\u20131312 (2016).","journal-title":"Obesity"},{"key":"1755_CR235","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.3390\/ijms20153775","volume":"20","author":"CA Meza","year":"2019","unstructured":"Meza, C. A., La Favor, J. D., Kim, D. H. & Hickner, R. C. Endothelial dysfunction: is there a hyperglycemia-induced imbalance of NOX and NOS? Int. J. Mol. Sci. 20, 3775 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR236","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1161\/CIRCRESAHA.112.266593","volume":"111","author":"F Paneni","year":"2012","unstructured":"Paneni, F. et al. Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes. Circ. Res. 111, 278\u2013289 (2012).","journal-title":"Circ. Res."},{"key":"1755_CR237","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1161\/ATVBAHA.107.156059","volume":"28","author":"F Cosentino","year":"2008","unstructured":"Cosentino, F. et al. Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arterioscler. Thromb. Vasc. Biol. 28, 622\u2013628 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1755_CR238","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.RES.87.10.840","volume":"87","author":"H Cai","year":"2000","unstructured":"Cai, H. & Harrison, D. G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ. Res. 87, 840\u2013844 (2000).","journal-title":"Circ. Res."},{"key":"1755_CR239","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.freeradbiomed.2017.12.017","volume":"115","author":"Y Liao","year":"2018","unstructured":"Liao, Y. et al. NADPH oxidase 4 and endothelial nitric oxide synthase contribute to endothelial dysfunction mediated by histone methylations in metabolic memory. Free Radic. Biol. Med. 115, 383\u2013394 (2018).","journal-title":"Free Radic. Biol. Med."},{"key":"1755_CR240","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.brainres.2012.05.043","volume":"1467","author":"G Rana","year":"2012","unstructured":"Rana, G. et al. Cortical spreading depression differentially affects lysine methylation of H3 histone at neuroprotective genes and retrotransposon sequences. Brain Res. 1467, 113\u2013119 (2012).","journal-title":"Brain Res."},{"key":"1755_CR241","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/cvr\/cvab013","volume":"118","author":"Y Yao","year":"2022","unstructured":"Yao, Y. et al. Endothelial cell metabolic memory causes cardiovascular dysfunction in diabetes. Cardiovasc. Res. 118, 196\u2013211 (2022).","journal-title":"Cardiovasc. Res."},{"key":"1755_CR242","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00125-015-3832-0","volume":"59","author":"S Zhao","year":"2016","unstructured":"Zhao, S. et al. miR-23b-3p induces the cellular metabolic memory of high glucose in diabetic retinopathy through a SIRT1-dependent signalling pathway. Diabetologia 59, 644\u2013654 (2016).","journal-title":"Diabetologia"},{"key":"1755_CR243","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1172\/JCI69557","volume":"124","author":"K Hayashi","year":"2014","unstructured":"Hayashi, K. et al. KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuria. J. Clin. Invest. 124, 2523\u20132537 (2014).","journal-title":"J. Clin. Invest."},{"key":"1755_CR244","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/nyas.12758","volume":"1353","author":"M Kato","year":"2015","unstructured":"Kato, M. & Natarajan, R. MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets. Ann. N. Y. Acad. Sci. 1353, 72\u201388 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1755_CR245","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.mce.2015.12.019","volume":"422","author":"S Kumar","year":"2016","unstructured":"Kumar, S., Pamulapati, H. & Tikoo, K. Fatty acid induced metabolic memory involves alterations in renal histone H3K36me2 and H3K27me3. Mol. Cell Endocrinol. 422, 233\u2013242 (2016).","journal-title":"Mol. Cell Endocrinol."},{"key":"1755_CR246","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-80072-z","volume":"11","author":"AHA Al-Rikabi","year":"2021","unstructured":"Al-Rikabi, A. H. A., Tobin, D. J., Riches-Suman, K. & Thornton, M. J. Dermal fibroblasts cultured from donors with type 2 diabetes mellitus retain an epigenetic memory associated with poor wound healing responses. Sci. Rep. 11, 1474 (2021).","journal-title":"Sci. Rep."},{"key":"1755_CR247","doi-asserted-by":"publisher","first-page":"E9162","DOI":"10.1073\/pnas.1720930115","volume":"115","author":"R Kamada","year":"2018","unstructured":"Kamada, R. et al. Interferon stimulation creates chromatin marks and establishes transcriptional memory. Proc. Natl Acad. Sci. USA 115, E9162\u2013e9171 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR248","doi-asserted-by":"publisher","first-page":"989844","DOI":"10.3389\/fendo.2022.989844","volume":"13","author":"T Bhamidipati","year":"2022","unstructured":"Bhamidipati, T. et al. Epigenetic basis of diabetic vasculopathy. Front. Endocrinol. 13, 989844 (2022).","journal-title":"Front. Endocrinol."},{"key":"1755_CR249","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.freeradbiomed.2022.10.304","volume":"193","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. MTHFR epigenetic derepression protects against diabetes cardiac fibrosis. Free Radic. Biol. Med. 193, 330\u2013341 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"1755_CR250","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.3390\/nu13124562","volume":"13","author":"S Raghubeer","year":"2021","unstructured":"Raghubeer, S. & Matsha, T. E. Methylenetetrahydrofolate (MTHFR), the one-carbon cycle, and cardiovascular risks. Nutrients 13, 4562 (2021).","journal-title":"Nutrients"},{"key":"1755_CR251","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3390\/biom13030558","volume":"13","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. High-fat diet related lung fibrosis-epigenetic regulation matters. Biomolecules 13, 558 (2023).","journal-title":"Biomolecules"},{"key":"1755_CR252","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.146","volume":"4","author":"SK Huang","year":"2013","unstructured":"Huang, S. K. et al. Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts. Cell Death Dis. 4, e621 (2013).","journal-title":"Cell Death Dis."},{"key":"1755_CR253","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26277-w","volume":"12","author":"C Pessoa Rodrigues","year":"2021","unstructured":"Pessoa Rodrigues, C. et al. Histone H4 lysine 16 acetylation controls central carbon metabolism and diet-induced obesity in mice. Nat. Commun. 12, 6212 (2021).","journal-title":"Nat. Commun."},{"key":"1755_CR254","doi-asserted-by":"publisher","first-page":"530","DOI":"10.7150\/thno.62760","volume":"12","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Modulation of H4K16Ac levels reduces pro-fibrotic gene expression and mitigates lung fibrosis in aged mice. Theranostics 12, 530\u2013541 (2022).","journal-title":"Theranostics"},{"key":"1755_CR255","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1016\/j.neuron.2023.05.003","volume":"111","author":"SA Eid","year":"2023","unstructured":"Eid, S. A. et al. New perspectives in diabetic neuropathy. Neuron 111, 2623\u20132641 (2023).","journal-title":"Neuron"},{"key":"1755_CR256","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/j.pain.0000000000000739","volume":"158","author":"CH Zhou","year":"2017","unstructured":"Zhou, C. H. et al. SIRT1 attenuates neuropathic pain by epigenetic regulation of mGluR1\/5 expressions in type 2 diabetic rats. Pain 158, 130\u2013139 (2017).","journal-title":"Pain"},{"key":"1755_CR257","doi-asserted-by":"publisher","first-page":"111502","DOI":"10.1016\/j.yexcr.2019.111502","volume":"383","author":"CH Zhang","year":"2019","unstructured":"Zhang, C. H. et al. The Akt\/mTOR cascade mediates high glucose-induced reductions in BDNF via DNMT1 in Schwann cells in diabetic peripheral neuropathy. Exp. Cell Res. 383, 111502 (2019).","journal-title":"Exp. Cell Res."},{"key":"1755_CR258","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1096\/fj.201900127R","volume":"33","author":"W Du","year":"2019","unstructured":"Du, W. et al. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy. FASEB J. 33, 8008\u20138021 (2019).","journal-title":"FASEB J."},{"key":"1755_CR259","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03930-2","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. TXNIP, a novel key factor to cause Schwann cell dysfunction in diabetic peripheral neuropathy, under the regulation of PI3K\/Akt pathway inhibition-induced DNMT1 and DNMT3a overexpression. Cell Death Dis. 12, 642 (2021).","journal-title":"Cell Death Dis."},{"key":"1755_CR260","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrd4231","volume":"13","author":"A Vetere","year":"2014","unstructured":"Vetere, A., Choudhary, A., Burns, S. M. & Wagner, B. K. Targeting the pancreatic \u03b2-cell to treat diabetes. Nat. Rev. Drug Discov. 13, 278\u2013289 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1755_CR261","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tem.2015.12.005","volume":"27","author":"SA Campbell","year":"2016","unstructured":"Campbell, S. A. & Hoffman, B. G. Chromatin regulators in pancreas development and diabetes. Trends Endocrinol. Metab. 27, 142\u2013152 (2016).","journal-title":"Trends Endocrinol. Metab."},{"key":"1755_CR262","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/jcm3030923","volume":"3","author":"Y Saisho","year":"2014","unstructured":"Saisho, Y. Importance of beta cell function for the treatment of type 2 diabetes. J. Clin. Med. 3, 923\u2013943 (2014).","journal-title":"J. Clin. Med."},{"key":"1755_CR263","doi-asserted-by":"publisher","first-page":"e1004160","DOI":"10.1371\/journal.pgen.1004160","volume":"10","author":"T Dayeh","year":"2014","unstructured":"Dayeh, T. et al. Genome-wide DNA methylation analysis of human pancreatic islets from type 2 diabetic and non-diabetic donors identifies candidate genes that influence insulin secretion. PLoS Genet. 10, e1004160 (2014).","journal-title":"PLoS Genet."},{"key":"1755_CR264","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.2337\/db16-0996","volume":"66","author":"P Volkov","year":"2017","unstructured":"Volkov, P. et al. Whole-genome bisulfite sequencing of human pancreatic islets reveals novel differentially methylated regions in type 2 diabetes pathogenesis. Diabetes 66, 1074\u20131085 (2017).","journal-title":"Diabetes"},{"key":"1755_CR265","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/15592294.2019.1582277","volume":"14","author":"M Franzago","year":"2019","unstructured":"Franzago, M., Fraticelli, F., Stuppia, L. & Vitacolonna, E. Nutrigenetics, epigenetics and gestational diabetes: consequences in mother and child. Epigenetics 14, 215\u2013235 (2019).","journal-title":"Epigenetics"},{"key":"1755_CR266","first-page":"203","volume":"22","author":"Z Nazari","year":"2020","unstructured":"Nazari, Z. et al. In utero exposure to gestational diabetes alters DNA methylation and gene expression of CDKN2A\/B in Langerhans islets of rat offspring. Cell J. 22, 203\u2013211 (2020).","journal-title":"Cell J."},{"key":"1755_CR267","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1007\/s00125-018-4735-7","volume":"61","author":"T Nammo","year":"2018","unstructured":"Nammo, T. et al. Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice. Diabetologia 61, 2608\u20132620 (2018).","journal-title":"Diabetologia"},{"key":"1755_CR268","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/en.2014-1906","volume":"156","author":"H Nomoto","year":"2015","unstructured":"Nomoto, H. et al. Inhibition of small Maf function in pancreatic \u03b2-Cells improves glucose tolerance through the enhancement of insulin gene transcription and insulin secretion. Endocrinology 156, 3570\u20133580 (2015).","journal-title":"Endocrinology"},{"key":"1755_CR269","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","volume":"241","author":"WB Kannel","year":"1979","unstructured":"Kannel, W. B. & McGee, D. L. Diabetes and cardiovascular disease. The Framingham study. J. Am. Med. Assoc. 241, 2035\u20132038 (1979).","journal-title":"J. Am. Med. Assoc."},{"key":"1755_CR270","doi-asserted-by":"publisher","first-page":"4589","DOI":"10.3390\/ijms23094589","volume":"23","author":"FR Prandi","year":"2022","unstructured":"Prandi, F. R. et al. Epigenetic modifications and non-coding RNA in diabetes-mellitus-induced coronary artery disease: pathophysiological link and new therapeutic frontiers. Int. J. Mol. Sci. 23, 4589 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR271","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/CCM.0b013e3181b4a854","volume":"38","author":"YH Kao","year":"2010","unstructured":"Kao, Y. H. et al. Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes. Crit. Care Med. 38, 217\u2013222 (2010).","journal-title":"Crit. Care Med."},{"key":"1755_CR272","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.carpath.2012.07.004","volume":"22","author":"M Asrih","year":"2013","unstructured":"Asrih, M. & Steffens, S. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy. Cardiovasc. Pathol. 22, 117\u2013125 (2013).","journal-title":"Cardiovasc. Pathol."},{"key":"1755_CR273","doi-asserted-by":"publisher","first-page":"e0143814","DOI":"10.1371\/journal.pone.0143814","volume":"10","author":"E Zhang","year":"2015","unstructured":"Zhang, E. et al. Metformin and resveratrol inhibited high glucose-induced metabolic memory of endothelial senescence through SIRT1\/p300\/p53\/p21 pathway. PLoS ONE 10, e0143814 (2015).","journal-title":"PLoS ONE"},{"key":"1755_CR274","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1101\/gad.1738708","volume":"22","author":"N Liu","year":"2008","unstructured":"Liu, N. et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev. 22, 3242\u20133254 (2008).","journal-title":"Genes Dev."},{"key":"1755_CR275","doi-asserted-by":"publisher","first-page":"7615","DOI":"10.3390\/ijms21207615","volume":"21","author":"M Giordano","year":"2020","unstructured":"Giordano, M. et al. Circulating MiRNA-195-5p and \u2212451a in diabetic patients with transient and acute ischemic stroke in the emergency department. Int. J. Mol. Sci. 21, 7615 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR276","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.2337\/dc13-1847","volume":"37","author":"FJ Ortega","year":"2014","unstructured":"Ortega, F. J. et al. Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care 37, 1375\u20131383 (2014).","journal-title":"Diabetes Care"},{"key":"1755_CR277","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/biom9050193","volume":"9","author":"MA Al-Hayali","year":"2019","unstructured":"Al-Hayali, M. A. et al. Clinical value of circulating microribonucleic acids miR-1 and miR-21 in evaluating the diagnosis of acute heart failure in asymptomatictype 2 diabetic patients. Biomolecules 9, 193 (2019).","journal-title":"Biomolecules"},{"key":"1755_CR278","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11892-015-0677-3","volume":"15","author":"J Pasquier","year":"2015","unstructured":"Pasquier, J. et al. Epigenetics and cardiovascular disease in diabetes. Curr. Diabetes Rep. 15, 108 (2015).","journal-title":"Curr. Diabetes Rep."},{"key":"1755_CR279","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","volume":"11","author":"CE Tabit","year":"2010","unstructured":"Tabit, C. E., Chung, W. B., Hamburg, N. M. & Vita, J. A. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev. Endocr. Metab. Disord. 11, 61\u201374 (2010).","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"1755_CR280","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1161\/ATVBAHA.116.308321","volume":"36","author":"Q Li","year":"2016","unstructured":"Li, Q. et al. P66Shc-induced microRNA-34a causes diabetic endothelial dysfunction by downregulating Sirtuin1. Arterioscler. Thromb. Vasc. Biol. 36, 2394\u20132403 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1755_CR281","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1111\/jcmm.14253","volume":"23","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. Inhibition of P53\/miR-34a improves diabetic endothelial dysfunction via activation of SIRT1. J. Cell Mol. Med. 23, 3538\u20133548 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"1755_CR282","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/ijms17040518","volume":"17","author":"M Silambarasan","year":"2016","unstructured":"Silambarasan, M. et al. MicroRNAs in hyperglycemia induced endothelial cell dysfunction. Int. J. Mol. Sci. 17, 518 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR283","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/eurheartj\/ehv599","volume":"37","author":"S Costantino","year":"2016","unstructured":"Costantino, S., Paneni, F., L\u00fcscher, T. F. & Cosentino, F. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart. Eur. Heart J. 37, 572\u2013576 (2016).","journal-title":"Eur. Heart J."},{"key":"1755_CR284","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1139\/cjpp-2015-0585","volume":"94","author":"KK Singh","year":"2016","unstructured":"Singh, K. K. et al. A global profile of glucose-sensitive endothelial-expressed long non-coding RNAs. Can. J. Physiol. Pharmacol. 94, 1007\u20131014 (2016).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"1755_CR285","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.bbrc.2018.03.187","volume":"499","author":"FF Shang","year":"2018","unstructured":"Shang, F. F., Luo, S., Liang, X. & Xia, Y. Alterations of circular RNAs in hyperglycemic human endothelial cells. Biochem. Biophys. Res. Commun. 499, 551\u2013555 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1755_CR286","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/15592294.2016.1278097","volume":"12","author":"L Sommese","year":"2017","unstructured":"Sommese, L. et al. Clinical relevance of epigenetics in the onset and management of type 2 diabetes mellitus. Epigenetics 12, 401\u2013415 (2017).","journal-title":"Epigenetics"},{"key":"1755_CR287","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2131\/jts.40.615","volume":"40","author":"P Li","year":"2015","unstructured":"Li, P. et al. Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells. J. Toxicol. Sci. 40, 615\u2013624 (2015).","journal-title":"J. Toxicol. Sci."},{"key":"1755_CR288","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.13262","volume":"20","author":"SC Bridgeman","year":"2018","unstructured":"Bridgeman, S. C. et al. Epigenetic effects of metformin: from molecular mechanisms to clinical implications. Diabetes Obes. Metab. 20, 1553\u20131562 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"1755_CR289","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/eurheartj\/ehx615","volume":"40","author":"S Costantino","year":"2019","unstructured":"Costantino, S. et al. Interplay among H3K9-editing enzymes SUV39H1, JMJD2C and SRC-1 drives p66Shc transcription and vascular oxidative stress in obesity. Eur. Heart J. 40, 383\u2013391 (2019).","journal-title":"Eur. Heart J."},{"key":"1755_CR290","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1161\/CIRCRESAHA.111.300233","volume":"112","author":"MA Kluge","year":"2013","unstructured":"Kluge, M. A., Fetterman, J. L. & Vita, J. A. Mitochondria and endothelial function. Circ. Res. 112, 1171\u20131188 (2013).","journal-title":"Circ. Res."},{"key":"1755_CR291","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04339-5","volume":"21","author":"J Dave","year":"2023","unstructured":"Dave, J., Jagana, V., Janostiak, R. & Bisserier, M. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. J. Transl. Med. 21, 477 (2023).","journal-title":"J. Transl. Med."},{"key":"1755_CR292","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1161\/CIRCULATIONAHA.109.916098","volume":"121","author":"SL Archer","year":"2010","unstructured":"Archer, S. L. et al. Epigenetic attenuation of mitochondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 121, 2661\u20132671 (2010).","journal-title":"Circulation"},{"key":"1755_CR293","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1161\/CIRCRESAHA.110.221259","volume":"107","author":"AJ Patterson","year":"2010","unstructured":"Patterson, A. J. et al. Chronic prenatal hypoxia induces epigenetic programming of PKC{epsilon} gene repression in rat hearts. Circ. Res. 107, 365\u2013373 (2010).","journal-title":"Circ. Res."},{"key":"1755_CR294","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.2337\/db18-0537","volume":"67","author":"ED Rosen","year":"2018","unstructured":"Rosen, E. D. et al. Epigenetics and epigenomics: implications for diabetes and obesity. Diabetes 67, 1923\u20131931 (2018).","journal-title":"Diabetes"},{"key":"1755_CR295","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cmet.2012.04.001","volume":"15","author":"CK Glass","year":"2012","unstructured":"Glass, C. K. & Olefsky, J. M. Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab. 15, 635\u2013645 (2012).","journal-title":"Cell Metab."},{"key":"1755_CR296","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4093\/dmj.2021.0280","volume":"46","author":"SH Lee","year":"2022","unstructured":"Lee, S. H., Park, S. Y. & Choi, C. S. Insulin resistance: from mechanisms to therapeutic strategies. Diabetes Metab. J. 46, 15\u201337 (2022).","journal-title":"Diabetes Metab. J."},{"key":"1755_CR297","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3390\/ijms20010128","volume":"20","author":"H Xu","year":"2018","unstructured":"Xu, H. et al. Etiology of metabolic syndrome and dietary intervention. Int. J. Mol. Sci. 20, 128 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR298","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.2337\/db17-1539","volume":"67","author":"A Abderrahmani","year":"2018","unstructured":"Abderrahmani, A. et al. Increased hepatic PDGF-AA signaling mediates liver insulin resistance in obesity-associated type 2 diabetes. Diabetes 67, 1310\u20131321 (2018).","journal-title":"Diabetes"},{"key":"1755_CR299","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2337\/db15-1716","volume":"66","author":"C Baumeier","year":"2017","unstructured":"Baumeier, C. et al. Hepatic DPP4 DNA methylation associates with fatty liver. Diabetes 66, 25\u201335 (2017).","journal-title":"Diabetes"},{"key":"1755_CR300","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cmet.2009.07.011","volume":"10","author":"R Barr\u00e8s","year":"2009","unstructured":"Barr\u00e8s, R. et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 10, 189\u2013198 (2009).","journal-title":"Cell Metab."},{"key":"1755_CR301","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.2337\/db13-1459","volume":"63","author":"E Nilsson","year":"2014","unstructured":"Nilsson, E. et al. Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes 63, 2962\u20132976 (2014).","journal-title":"Diabetes"},{"key":"1755_CR302","doi-asserted-by":"publisher","first-page":"E1491","DOI":"10.1210\/jc.2015-3204","volume":"100","author":"E Nilsson","year":"2015","unstructured":"Nilsson, E. et al. Epigenetic alterations in human liver from subjects with type 2 diabetes in parallel with reduced folate levels. J. Clin. Endocrinol. Metab. 100, E1491\u20131501, (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1755_CR303","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.2337\/db11-1653","volume":"61","author":"MD Nitert","year":"2012","unstructured":"Nitert, M. D. et al. Impact of an exercise intervention on DNA methylation in skeletal muscle from first-degree relatives of patients with type 2 diabetes. Diabetes 61, 3322\u20133332 (2012).","journal-title":"Diabetes"},{"key":"1755_CR304","doi-asserted-by":"publisher","first-page":"e51302","DOI":"10.1371\/journal.pone.0051302","volume":"7","author":"R Ribel-Madsen","year":"2012","unstructured":"Ribel-Madsen, R. et al. Genome-wide analysis of DNA methylation differences in muscle and fat from monozygotic twins discordant for type 2 diabetes. PLoS ONE 7, e51302 (2012).","journal-title":"PLoS ONE"},{"key":"1755_CR305","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molmet.2015.12.004","volume":"5","author":"H Kirchner","year":"2016","unstructured":"Kirchner, H. et al. Altered DNA methylation of glycolytic and lipogenic genes in liver from obese and type 2 diabetic patients. Mol. Metab. 5, 171\u2013183 (2016).","journal-title":"Mol. Metab."},{"key":"1755_CR306","first-page":"3792","volume":"24","author":"T R\u00f6nn","year":"2015","unstructured":"R\u00f6nn, T. et al. Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood. Hum. Mol. Genet. 24, 3792\u20133813 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"1755_CR307","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.molmet.2016.11.003","volume":"6","author":"M Keller","year":"2017","unstructured":"Keller, M. et al. Genome-wide DNA promoter methylation and transcriptome analysis in human adipose tissue unravels novel candidate genes for obesity. Mol. Metab. 6, 86\u2013100 (2017).","journal-title":"Mol. Metab."},{"key":"1755_CR308","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0792-x","volume":"15","author":"C Daveg\u00e5rdh","year":"2017","unstructured":"Daveg\u00e5rdh, C. et al. Abnormal epigenetic changes during differentiation of human skeletal muscle stem cells from obese subjects. BMC Med. 15, 39 (2017).","journal-title":"BMC Med."},{"key":"1755_CR309","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12081-0","volume":"10","author":"S Gancheva","year":"2019","unstructured":"Gancheva, S. et al. Dynamic changes of muscle insulin sensitivity after metabolic surgery. Nat. Commun. 10, 4179 (2019).","journal-title":"Nat. Commun."},{"key":"1755_CR310","doi-asserted-by":"publisher","first-page":"e30766","DOI":"10.7554\/eLife.30766","volume":"6","author":"D You","year":"2017","unstructured":"You, D. et al. Dnmt3a is an epigenetic mediator of adipose insulin resistance. Elife 6, e30766 (2017).","journal-title":"Elife"},{"key":"1755_CR311","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00125-007-0916-5","volume":"51","author":"C Ling","year":"2008","unstructured":"Ling, C. et al. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia 51, 615\u2013622 (2008).","journal-title":"Diabetologia"},{"key":"1755_CR312","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s00125-010-1967-6","volume":"54","author":"BT Yang","year":"2011","unstructured":"Yang, B. T. et al. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia 54, 360\u2013367 (2011).","journal-title":"Diabetologia"},{"key":"1755_CR313","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/me.2012-1004","volume":"26","author":"BT Yang","year":"2012","unstructured":"Yang, B. T. et al. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol. Endocrinol. 26, 1203\u20131212 (2012).","journal-title":"Mol. Endocrinol."},{"key":"1755_CR314","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1038\/emboj.2011.503","volume":"31","author":"M Volkmar","year":"2012","unstructured":"Volkmar, M. et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. Embo J. 31, 1405\u20131426 (2012).","journal-title":"Embo J."},{"key":"1755_CR315","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0522-z","volume":"15","author":"E Hall","year":"2014","unstructured":"Hall, E. et al. Sex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic islets. Genome Biol. 15, 522 (2014).","journal-title":"Genome Biol."},{"key":"1755_CR316","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.2337\/db18-0393","volume":"67","author":"S Khetan","year":"2018","unstructured":"Khetan, S. et al. Type 2 diabetes-associated genetic variants regulate chromatin accessibility in human islets. Diabetes 67, 2466\u20132477 (2018).","journal-title":"Diabetes"},{"key":"1755_CR317","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.mce.2017.11.019","volume":"472","author":"E Hall","year":"2018","unstructured":"Hall, E. et al. The effects of high glucose exposure on global gene expression and DNA methylation in human pancreatic islets. Mol. Cell Endocrinol. 472, 57\u201367 (2018).","journal-title":"Mol. Cell Endocrinol."},{"key":"1755_CR318","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.2337\/db18-0900","volume":"68","author":"E Hall","year":"2019","unstructured":"Hall, E. et al. Glucolipotoxicity alters insulin secretion via epigenetic changes in human islets. Diabetes 68, 1965\u20131974 (2019).","journal-title":"Diabetes"},{"key":"1755_CR319","first-page":"2316","volume":"118","author":"JH Park","year":"2008","unstructured":"Park, J. H., Stoffers, D. A., Nicholls, R. D. & Simmons, R. A. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest. 118, 2316\u20132324 (2008).","journal-title":"J. Clin. Invest."},{"key":"1755_CR320","doi-asserted-by":"publisher","first-page":"2201714","DOI":"10.1080\/15592294.2023.2201714","volume":"18","author":"S Sultan","year":"2023","unstructured":"Sultan, S. & AlMalki, S. Analysis of global DNA methylation and epigenetic modifiers (DNMTs and HDACs) in human foetal endothelium exposed to gestational and type 2 diabetes. Epigenetics 18, 2201714 (2023).","journal-title":"Epigenetics"},{"key":"1755_CR321","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/23716","volume":"400","author":"A Apelqvist","year":"1999","unstructured":"Apelqvist, A. et al. Notch signalling controls pancreatic cell differentiation. Nature 400, 877\u2013881 (1999).","journal-title":"Nature"},{"key":"1755_CR322","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1101\/gad.12.12.1763","volume":"12","author":"U Ahlgren","year":"1998","unstructured":"Ahlgren, U. et al. beta-cell-specific inactivation of the mouse Ipf1\/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev. 12, 1763\u20131768 (1998).","journal-title":"Genes Dev."},{"key":"1755_CR323","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ng1097-138","volume":"17","author":"DA Stoffers","year":"1997","unstructured":"Stoffers, D. A., Ferrer, J., Clarke, W. L. & Habener, J. F. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat. Genet. 17, 138\u2013139 (1997).","journal-title":"Nat. Genet."},{"key":"1755_CR324","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrendo.2017.97","volume":"13","author":"JD Gray","year":"2017","unstructured":"Gray, J. D., Kogan, J. F., Marrocco, J. & McEwen, B. S. Genomic and epigenomic mechanisms of glucocorticoids in the brain. Nat. Rev. Endocrinol. 13, 661\u2013673 (2017).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1755_CR325","doi-asserted-by":"publisher","first-page":"e90277","DOI":"10.1371\/journal.pone.0090277","volume":"9","author":"C Murgatroyd","year":"2014","unstructured":"Murgatroyd, C. & Spengler, D. Polycomb binding precedes early-life stress responsive DNA methylation at the Avp enhancer. PLoS One 9, e90277 (2014).","journal-title":"PLoS One"},{"key":"1755_CR326","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/nn.2436","volume":"12","author":"C Murgatroyd","year":"2009","unstructured":"Murgatroyd, C. et al. Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat. Neurosci. 12, 1559\u20131566 (2009).","journal-title":"Nat. Neurosci."},{"key":"1755_CR327","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ejphar.2018.06.034","volume":"833","author":"S Dewanjee","year":"2018","unstructured":"Dewanjee, S. et al. Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets. Eur. J. Pharmacol. 833, 472\u2013523 (2018).","journal-title":"Eur. J. Pharmacol."},{"key":"1755_CR328","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.phrs.2013.12.005","volume":"80","author":"R Singh","year":"2014","unstructured":"Singh, R., Kishore, L. & Kaur, N. Diabetic peripheral neuropathy: current perspective and future directions. Pharm. Res. 80, 21\u201335 (2014).","journal-title":"Pharm. Res."},{"key":"1755_CR329","doi-asserted-by":"publisher","first-page":"2494057","DOI":"10.1155\/2019\/2494057","volume":"2019","author":"HH Zhang","year":"2019","unstructured":"Zhang, H. H. et al. The association between genomic DNA methylation and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. J. Diabetes Res. 2019, 2494057 (2019).","journal-title":"J. Diabetes Res."},{"key":"1755_CR330","doi-asserted-by":"publisher","first-page":"3425617","DOI":"10.1155\/2016\/3425617","volume":"2016","author":"LM Rom\u00e1n-Pintos","year":"2016","unstructured":"Rom\u00e1n-Pintos, L. M. et al. Diabetic polyneuropathy in type 2 diabetes mellitus: inflammation, oxidative stress, and mitochondrial function. J. Diabetes Res. 2016, 3425617 (2016).","journal-title":"J. Diabetes Res."},{"key":"1755_CR331","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0073-5","volume":"7","author":"M Ollikainen","year":"2015","unstructured":"Ollikainen, M. et al. Genome-wide blood DNA methylation alterations at regulatory elements and heterochromatic regions in monozygotic twins discordant for obesity and liver fat. Clin. Epigenetics 7, 39 (2015).","journal-title":"Clin. Epigenetics"},{"key":"1755_CR332","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00913-6","volume":"12","author":"K Guo","year":"2020","unstructured":"Guo, K. et al. Genome-wide profiling of DNA methylation and gene expression identifies candidate genes for human diabetic neuropathy. Clin. Epigenetics 12, 123 (2020).","journal-title":"Clin. Epigenetics"},{"key":"1755_CR333","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1080\/15592294.2019.1615352","volume":"14","author":"K Guo","year":"2019","unstructured":"Guo, K. et al. Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus. Epigenetics 14, 766\u2013779 (2019).","journal-title":"Epigenetics"},{"key":"1755_CR334","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman, E. L., Nave, K. A., Jensen, T. S. & Bennett, D. L. H. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron 93, 1296\u20131313 (2017).","journal-title":"Neuron"},{"key":"1755_CR335","doi-asserted-by":"publisher","first-page":"9028","DOI":"10.1523\/JNEUROSCI.1068-13.2013","volume":"33","author":"HH Zhang","year":"2013","unstructured":"Zhang, H. H. et al. Promoted interaction of nuclear factor-\u03baB with demethylated cystathionine-\u03b2-synthetase gene contributes to gastric hypersensitivity in diabetic rats. J. Neurosci. 33, 9028\u20139038 (2013).","journal-title":"J. Neurosci."},{"key":"1755_CR336","doi-asserted-by":"publisher","first-page":"4272","DOI":"10.2337\/db15-0138","volume":"64","author":"HH Zhang","year":"2015","unstructured":"Zhang, H. H. et al. Promoted interaction of nuclear factor-\u03baB with demethylated purinergic P2X3 receptor gene contributes to neuropathic pain in rats with diabetes. Diabetes 64, 4272\u20134284 (2015).","journal-title":"Diabetes"},{"key":"1755_CR337","doi-asserted-by":"publisher","first-page":"117459","DOI":"10.1016\/j.lfs.2020.117459","volume":"248","author":"YP Liu","year":"2020","unstructured":"Liu, Y. P., Shao, S. J. & Guo, H. D. Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy. Life Sci. 248, 117459 (2020).","journal-title":"Life Sci."},{"key":"1755_CR338","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2020.07.002","volume":"32","author":"LA Thielen","year":"2020","unstructured":"Thielen, L. A. et al. Identification of an anti-diabetic, orally available small molecule that regulates TXNIP expression and glucagon action. Cell Metab. 32, 353\u2013365.e358 (2020).","journal-title":"Cell Metab."},{"key":"1755_CR339","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/glia.23755","volume":"68","author":"AR Hackett","year":"2020","unstructured":"Hackett, A. R., Strickland, A. & Milbrandt, J. Disrupting insulin signaling in Schwann cells impairs myelination and induces a sensory neuropathy. Glia 68, 963\u2013978 (2020).","journal-title":"Glia"},{"key":"1755_CR340","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuroscience.2013.10.038","volume":"256","author":"S Chen","year":"2014","unstructured":"Chen, S. et al. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation. Neuroscience 256, 137\u2013146 (2014).","journal-title":"Neuroscience"},{"key":"1755_CR341","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2147\/DDDT.S348055","volume":"16","author":"D Cheng","year":"2022","unstructured":"Cheng, D., Yang, S., Zhao, X. & Wang, G. The role of glucagon-like peptide-1 receptor agonists (GLP-1 RA) in diabetes-related neurodegenerative diseases. Drug Des. Dev. Ther. 16, 665\u2013684 (2022).","journal-title":"Drug Des. Dev. Ther."},{"key":"1755_CR342","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbadis.2018.11.012","volume":"1865","author":"S Chen","year":"2019","unstructured":"Chen, S. et al. Evidence of metabolic memory-induced neurodegeneration and the therapeutic effects of glucagon-like peptide-1 receptor agonists via Forkhead box class O. Biochim. Biophys. Acta Mol. Basis Dis. 1865, 371\u2013377 (2019).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1755_CR343","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbrc.2008.11.110","volume":"378","author":"CJ Chen","year":"2009","unstructured":"Chen, C. J. et al. Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway. Biochem. Biophys. Res. Commun. 378, 389\u2013393 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1755_CR344","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1080\/15384101.2015.1123355","volume":"15","author":"R Liang","year":"2016","unstructured":"Liang, R. et al. Evidence for AKT-independent regulation of FOXO1 and FOXO3 in haematopoietic stem and progenitor cells. Cell Cycle 15, 861\u2013867 (2016).","journal-title":"Cell Cycle"},{"key":"1755_CR345","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1007\/s12035-016-9700-1","volume":"54","author":"W Liu","year":"2017","unstructured":"Liu, W. et al. miR-9 mediates CALHM1-activated ATP-P2X7R signal in painful diabetic neuropathy rats. Mol. Neurobiol. 54, 922\u2013929 (2017).","journal-title":"Mol. Neurobiol."},{"key":"1755_CR346","doi-asserted-by":"publisher","first-page":"103924","DOI":"10.1016\/j.mvr.2019.103924","volume":"127","author":"KN Amin","year":"2020","unstructured":"Amin, K. N. et al. miR-23c regulates wound healing by targeting stromal cell-derived factor-1\u03b1 (SDF-1\u03b1\/CXCL12) among patients with diabetic foot ulcer. Microvasc. Res. 127, 103924 (2020).","journal-title":"Microvasc. Res."},{"key":"1755_CR347","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.2337\/db15-1283","volume":"65","author":"Y Wang","year":"2016","unstructured":"Wang, Y. et al. microRNA-182 mediates Sirt1-induced diabetic corneal nerve regeneration. Diabetes 65, 2020\u20132031 (2016).","journal-title":"Diabetes"},{"key":"1755_CR348","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.neuroscience.2013.11.057","volume":"259","author":"L Wang","year":"2014","unstructured":"Wang, L. et al. The role of miR-146a in dorsal root ganglia neurons of experimental diabetic peripheral neuropathy. Neuroscience 259, 155\u2013163 (2014).","journal-title":"Neuroscience"},{"key":"1755_CR349","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/DDDT.S157109","volume":"12","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Des. Devel Ther. 12, 171\u2013177 (2018).","journal-title":"Drug Des. Devel Ther."},{"key":"1755_CR350","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3389\/fnmol.2017.00126","volume":"10","author":"S Su","year":"2017","unstructured":"Su, S. et al. MiR-30b attenuates neuropathic pain by regulating voltage-gated sodium channel Nav1.3 in rats. Front. Mol. Neurosci. 10, 126 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"1755_CR351","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.intimp.2017.01.027","volume":"46","author":"XT Yan","year":"2017","unstructured":"Yan, X. T. et al. MicroRNA-93 alleviates neuropathic pain through targeting signal transducer and activator of transcription 3. Int. Immunopharmacol. 46, 156\u2013162 (2017).","journal-title":"Int. Immunopharmacol."},{"key":"1755_CR352","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fncel.2013.00220","volume":"7","author":"M Coolen","year":"2013","unstructured":"Coolen, M., Katz, S. & Bally-Cuif, L. miR-9: a versatile regulator of neurogenesis. Front. Cell Neurosci. 7, 220 (2013).","journal-title":"Front. Cell Neurosci."},{"key":"1755_CR353","doi-asserted-by":"publisher","first-page":"E1963","DOI":"10.1073\/pnas.1204023109","volume":"109","author":"Z Ma","year":"2012","unstructured":"Ma, Z. et al. Calcium homeostasis modulator 1 (CALHM1) is the pore-forming subunit of an ion channel that mediates extracellular Ca2+ regulation of neuronal excitability. Proc. Natl Acad. Sci. USA 109, E1963\u2013E1971 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR354","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.tins.2006.03.003","volume":"29","author":"CM Anderson","year":"2006","unstructured":"Anderson, C. M. & Nedergaard, M. Emerging challenges of assigning P2X7 receptor function and immunoreactivity in neurons. Trends Neurosci. 29, 257\u2013262 (2006).","journal-title":"Trends Neurosci."},{"key":"1755_CR355","first-page":"2941297","volume":"2017","author":"W Yu","year":"2017","unstructured":"Yu, W. et al. LncRNA NONRATT021972 was associated with neuropathic pain scoring in patients with type 2 diabetes. Behav. Neurol. 2017, 2941297 (2017).","journal-title":"Behav. Neurol."},{"key":"1755_CR356","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11302-015-9488-x","volume":"12","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia. Purinergic Signal. 12, 139\u2013148 (2016).","journal-title":"Purinergic Signal."},{"key":"1755_CR357","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuroscience.2018.01.049","volume":"374","author":"C Liu","year":"2018","unstructured":"Liu, C. et al. Long non-coding RNA BC168687 is Involved in TRPV1-mediated diabetic neuropathic pain in rats. Neuroscience 374, 214\u2013222 (2018).","journal-title":"Neuroscience"},{"key":"1755_CR358","doi-asserted-by":"publisher","first-page":"e12528","DOI":"10.1111\/cpr.12528","volume":"52","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Emerging roles of long non-coding RNAs in neuropathic pain. Cell Prolif. 52, e12528 (2019).","journal-title":"Cell Prolif."},{"key":"1755_CR359","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11302-016-9500-0","volume":"12","author":"H Xu","year":"2016","unstructured":"Xu, H. et al. LncRNA NONRATT021972 siRNA attenuates P2X7 receptor expression and inflammatory cytokine production induced by combined high glucose and free fatty acids in PC12 cells. Purinergic Signal. 12, 259\u2013268 (2016).","journal-title":"Purinergic Signal."},{"key":"1755_CR360","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.autneu.2016.04.001","volume":"197","author":"B Wu","year":"2016","unstructured":"Wu, B. et al. LncRNA uc.48+ siRNA improved diabetic sympathetic neuropathy in type 2 diabetic rats mediated by P2X7 receptor in SCG. Auton. Neurosci. 197, 14\u201318 (2016).","journal-title":"Auton. Neurosci."},{"key":"1755_CR361","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12035-015-9632-1","volume":"54","author":"H Peng","year":"2017","unstructured":"Peng, H. et al. lncRNA NONRATT021972 siRNA decreases diabetic neuropathic pain mediated by the P2X(3) receptor in dorsal root ganglia. Mol. Neurobiol. 54, 511\u2013523 (2017).","journal-title":"Mol. Neurobiol."},{"key":"1755_CR362","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/JAD-180314","volume":"65","author":"R Chen","year":"2018","unstructured":"Chen, R. et al. Morphological and pathological characteristics of brain in diabetic encephalopathy. J. Alzheimers Dis. 65, 15\u201328 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"1755_CR363","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00592-010-0218-0","volume":"47","author":"AA Sima","year":"2010","unstructured":"Sima, A. A. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 47, 279\u2013293 (2010).","journal-title":"Acta Diabetol."},{"key":"1755_CR364","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.3390\/ijms22094887","volume":"22","author":"M Jankovic","year":"2021","unstructured":"Jankovic, M. et al. Genetic and epigenomic modifiers of diabetic neuropathy. Int. J. Mol. Sci. 22, 4887 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR365","doi-asserted-by":"publisher","first-page":"598326","DOI":"10.3389\/fphar.2020.598326","volume":"11","author":"S Raj","year":"2020","unstructured":"Raj, S., Dsouza, L. A., Singh, S. P. & Kanwal, A. Sirt6 deacetylase: a potential key regulator in the prevention of obesity, diabetes and neurodegenerative disease. Front. Pharmacol. 11, 598326 (2020).","journal-title":"Front. Pharmacol."},{"key":"1755_CR366","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10787-023-01187-z","volume":"31","author":"V Kakoty","year":"2023","unstructured":"Kakoty, V. et al. Brain insulin resistance linked Alzheimer\u2019s and Parkinson\u2019s disease pathology: an undying implication of epigenetic and autophagy modulation. Inflammopharmacology 31, 699\u2013716 (2023).","journal-title":"Inflammopharmacology"},{"key":"1755_CR367","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.bbadis.2016.08.018","volume":"1863","author":"R Kandimalla","year":"2017","unstructured":"Kandimalla, R., Thirumala, V. & Reddy, P. H. Is Alzheimer\u2019s disease a Type 3 Diabetes? A critical appraisal. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 1078\u20131089 (2017).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1755_CR368","doi-asserted-by":"publisher","first-page":"e1001717","DOI":"10.1371\/journal.pbio.1001717","volume":"11","author":"M Mielcarek","year":"2013","unstructured":"Mielcarek, M. et al. HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol. 11, e1001717 (2013).","journal-title":"PLoS Biol."},{"key":"1755_CR369","doi-asserted-by":"publisher","first-page":"113427","DOI":"10.1016\/j.biopha.2022.113427","volume":"153","author":"Y Xu","year":"2022","unstructured":"Xu, Y. et al. Radix polygoni multiflori protects against hippocampal neuronal apoptosis in diabetic encephalopathy by inhibiting the HDAC4\/JNK pathway. Biomed. Pharmacother. 153, 113427 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"1755_CR370","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.brainresbull.2022.08.007","volume":"188","author":"L Jiang","year":"2022","unstructured":"Jiang, L. et al. Advanced glycation end products induce A\u03b2(1-42) deposition and cognitive decline through H19\/miR-15b\/BACE1 axis in diabetic encephalopathy. Brain Res. Bull. 188, 187\u2013196 (2022).","journal-title":"Brain Res. Bull."},{"key":"1755_CR371","doi-asserted-by":"publisher","first-page":"843","DOI":"10.3233\/JAD-215589","volume":"87","author":"R Zhang","year":"2022","unstructured":"Zhang, R. et al. Advanced glycosylation end products induced synaptic deficits and cognitive decline through ROS-JNK-p53\/miR-34c\/SYT1 axis in diabetic encephalopathy. J. Alzheimers Dis. 87, 843\u2013861 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"1755_CR372","doi-asserted-by":"publisher","first-page":"114212","DOI":"10.1016\/j.expneurol.2022.114212","volume":"358","author":"Y Tu","year":"2022","unstructured":"Tu, Y. et al. MiR-702-5p ameliorates diabetic encephalopathy in db\/db mice by regulating 12\/15-LOX. Exp. Neurol. 358, 114212 (2022).","journal-title":"Exp. Neurol."},{"key":"1755_CR373","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/ph16020305","volume":"16","author":"J Li","year":"2023","unstructured":"Li, J., Xu, S., Wang, L. & Wang, X. PHPB attenuated cognitive impairment in type 2 diabetic KK-Ay mice by modulating SIRT1\/insulin signaling pathway and inhibiting generation of AGEs. Pharmceuticals 16, 305 (2023).","journal-title":"Pharmceuticals"},{"key":"1755_CR374","doi-asserted-by":"publisher","first-page":"4590","DOI":"10.18632\/aging.202418","volume":"13","author":"L Shi","year":"2020","unstructured":"Shi, L. et al. Decreased miR-132 plays a crucial role in diabetic encephalopathy by regulating the GSK-3\u03b2\/Tau pathway. Aging (Albany NY). 13, 4590\u20134604 (2020).","journal-title":"Aging (Albany NY)."},{"key":"1755_CR375","doi-asserted-by":"publisher","first-page":"147702","DOI":"10.1016\/j.brainres.2021.147702","volume":"1774","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. The circRNA circ-Nbea participates in regulating diabetic encephalopathy. Brain Res. 1774, 147702 (2022).","journal-title":"Brain Res."},{"key":"1755_CR376","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.neulet.2016.05.031","volume":"626","author":"J Chen","year":"2016","unstructured":"Chen, J. et al. MicroRNA-128-3p impaired water maze learning by suppressing Doublecortin expression in both wild type and A\u03b2-42 infused mice. Neurosci. Lett. 626, 79\u201385 (2016).","journal-title":"Neurosci. Lett."},{"key":"1755_CR377","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1002\/jcp.27300","volume":"234","author":"XY Wang","year":"2019","unstructured":"Wang, X. Y., Zhang, X. Z., Li, F. & Ji, Q. R. MiR-128-3p accelerates cardiovascular calcification and insulin resistance through ISL1-dependent Wnt pathway in type 2 diabetes mellitus rats. J. Cell Physiol. 234, 4997\u20135010 (2019).","journal-title":"J. Cell Physiol."},{"key":"1755_CR378","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.pathol.4.110807.092150","volume":"6","author":"YS Kanwar","year":"2011","unstructured":"Kanwar, Y. S. et al. A glimpse of various pathogenetic mechanisms of diabetic nephropathy. Annu. Rev. Pathol. 6, 395\u2013423 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"1755_CR379","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.kint.2018.01.036","volume":"93","author":"C Qiu","year":"2018","unstructured":"Qiu, C. et al. Cytosine methylation predicts renal function decline in American Indians. Kidney Int. 93, 1417\u20131431 (2018).","journal-title":"Kidney Int."},{"key":"1755_CR380","doi-asserted-by":"publisher","first-page":"6835","DOI":"10.1074\/jbc.M112.419101","volume":"288","author":"A Shah","year":"2013","unstructured":"Shah, A. et al. Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J. Biol. Chem. 288, 6835\u20136848 (2013).","journal-title":"J. Biol. Chem."},{"key":"1755_CR381","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1681\/ASN.2014050528","volume":"26","author":"A Shah","year":"2015","unstructured":"Shah, A. et al. Thioredoxin-interacting protein deficiency protects against diabetic nephropathy. J. Am. Soc. Nephrol. 26, 2963\u20132977 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1755_CR382","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nm.2135","volume":"16","author":"W Bechtel","year":"2010","unstructured":"Bechtel, W. et al. Methylation determines fibroblast activation and fibrogenesis in the kidney. Nat. Med. 16, 544\u2013550 (2010).","journal-title":"Nat. Med."},{"key":"1755_CR383","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1681\/ASN.2013070723","volume":"25","author":"B Tampe","year":"2014","unstructured":"Tampe, B. et al. Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis. J. Am. Soc. Nephrol. 25, 905\u2013912 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1755_CR384","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/ki.2013.387","volume":"85","author":"MA Reddy","year":"2014","unstructured":"Reddy, M. A. et al. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db\/db mice. Kidney Int. 85, 362\u2013373 (2014).","journal-title":"Kidney Int."},{"key":"1755_CR385","doi-asserted-by":"publisher","first-page":"654148","DOI":"10.1155\/2014\/654148","volume":"2014","author":"GD Sun","year":"2014","unstructured":"Sun, G. D., Cui, W. P., Guo, Q. Y. & Miao, L. N. Histone lysine methylation in diabetic nephropathy. J. Diabetes Res. 2014, 654148 (2014).","journal-title":"J. Diabetes Res."},{"key":"1755_CR386","doi-asserted-by":"publisher","first-page":"18091","DOI":"10.1074\/jbc.M311786200","volume":"279","author":"F Miao","year":"2004","unstructured":"Miao, F., Gonzalo, I. G., Lanting, L. & Natarajan, R. In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions. J. Biol. Chem. 279, 18091\u201318097 (2004).","journal-title":"J. Biol. Chem."},{"key":"1755_CR387","doi-asserted-by":"publisher","first-page":"13854","DOI":"10.1074\/jbc.M609446200","volume":"282","author":"F Miao","year":"2007","unstructured":"Miao, F. et al. Genome-wide analysis of histone lysine methylation variations caused by diabetic conditions in human monocytes. J. Biol. Chem. 282, 13854\u201313863 (2007).","journal-title":"J. Biol. Chem."},{"key":"1755_CR388","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.2337\/db08-0645","volume":"57","author":"F Miao","year":"2008","unstructured":"Miao, F. et al. Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes 57, 3189\u20133198 (2008).","journal-title":"Diabetes"},{"key":"1755_CR389","doi-asserted-by":"publisher","first-page":"26771","DOI":"10.1074\/jbc.M802800200","volume":"283","author":"Y Li","year":"2008","unstructured":"Li, Y. et al. Role of the histone H3 lysine 4 methyltransferase, SET7\/9, in the regulation of NF-kappaB-dependent inflammatory genes. Relevance to diabetes and inflammation. J. Biol. Chem. 283, 26771\u201326781 (2008).","journal-title":"J. Biol. Chem."},{"key":"1755_CR390","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3390\/cells12030431","volume":"12","author":"N Di Pietrantonio","year":"2023","unstructured":"Di Pietrantonio, N. et al. Diabetes and its cardiovascular complications: potential role of the acetyltransferase p300. Cells 12, 431 (2023).","journal-title":"Cells"},{"key":"1755_CR391","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jcp.21162","volume":"213","author":"AK Ghosh","year":"2007","unstructured":"Ghosh, A. K. & Varga, J. The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis. J. Cell Physiol. 213, 663\u2013671 (2007).","journal-title":"J. Cell Physiol."},{"key":"1755_CR392","doi-asserted-by":"publisher","first-page":"F601","DOI":"10.1152\/ajprenal.00523.2012","volume":"304","author":"H Yuan","year":"2013","unstructured":"Yuan, H. et al. Involvement of p300\/CBP and epigenetic histone acetylation in TGF-\u03b21-mediated gene transcription in mesangial cells. Am. J. Physiol. Ren. Physiol. 304, F601\u2013F613 (2013).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"1755_CR393","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000505295","volume":"6","author":"L Nie","year":"2020","unstructured":"Nie, L., Liu, Y., Zhang, B. & Zhao, J. Application of histone deacetylase inhibitors in renal interstitial fibrosis. Kidney Dis. (Basel). 6, 226\u2013235 (2020).","journal-title":"Kidney Dis. (Basel)."},{"key":"1755_CR394","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s10020-022-00559-5","volume":"28","author":"M Mladenov","year":"2022","unstructured":"Mladenov, M. et al. Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications. Mol. Med. 28, 129 (2022).","journal-title":"Mol. Med."},{"key":"1755_CR395","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1073\/pnas.0611192104","volume":"104","author":"M Kato","year":"2007","unstructured":"Kato, M. et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl Acad. Sci. USA 104, 3432\u20133437 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR396","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1681\/ASN.2011050485","volume":"23","author":"S Putta","year":"2012","unstructured":"Putta, S. et al. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. J. Am. Soc. Nephrol. 23, 458\u2013469 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1755_CR397","doi-asserted-by":"publisher","first-page":"ra43","DOI":"10.1126\/scisignal.2003389","volume":"6","author":"M Kato","year":"2013","unstructured":"Kato, M. et al. TGF-\u03b2 induces acetylation of chromatin and of Ets-1 to alleviate repression of miR-192 in diabetic nephropathy. Sci. Signal. 6, ra43 (2013).","journal-title":"Sci. Signal."},{"key":"1755_CR398","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.2337\/db13-0305","volume":"62","author":"SD Deshpande","year":"2013","unstructured":"Deshpande, S. D. et al. Transforming growth factor-\u03b2-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy. Diabetes 62, 3151\u20133162 (2013).","journal-title":"Diabetes"},{"key":"1755_CR399","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1681\/ASN.2010020134","volume":"21","author":"AC Chung","year":"2010","unstructured":"Chung, A. C., Huang, X. R., Meng, X. & Lan, H. Y. miR-192 mediates TGF-beta\/Smad3-driven renal fibrosis. J. Am. Soc. Nephrol. 21, 1317\u20131325 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1755_CR400","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ymthe.2016.08.001","volume":"25","author":"M K\u00f6lling","year":"2017","unstructured":"K\u00f6lling, M. et al. Therapeutic miR-21 silencing ameliorates diabetic kidney disease in mice. Mol. Ther. 25, 165\u2013180 (2017).","journal-title":"Mol. Ther."},{"key":"1755_CR401","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.bbrc.2017.12.048","volume":"498","author":"M Xue","year":"2018","unstructured":"Xue, M. et al. High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells. Biochem. Biophys. Res. Commun. 498, 38\u201344 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1755_CR402","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bbrc.2016.12.145","volume":"483","author":"J Sun","year":"2017","unstructured":"Sun, J., Li, Z. P., Zhang, R. Q. & Zhang, H. M. Repression of miR-217 protects against high glucose-induced podocyte injury and insulin resistance by restoring PTEN-mediated autophagy pathway. Biochem. Biophys. Res. Commun. 483, 318\u2013324 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1755_CR403","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.vph.2018.01.007","volume":"114","author":"A Leung","year":"2019","unstructured":"Leung, A., Amaram, V. & Natarajan, R. Linking diabetic vascular complications with LncRNAs. Vasc. Pharmacol. 114, 139\u2013144 (2019).","journal-title":"Vasc. Pharmacol."},{"key":"1755_CR404","doi-asserted-by":"publisher","first-page":"e18671","DOI":"10.1371\/journal.pone.0018671","volume":"6","author":"ML Alvarez","year":"2011","unstructured":"Alvarez, M. L. & DiStefano, J. K. Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathy. PLoS ONE 6, e18671 (2011).","journal-title":"PLoS ONE"},{"key":"1755_CR405","doi-asserted-by":"publisher","first-page":"e0168353","DOI":"10.1371\/journal.pone.0168353","volume":"11","author":"ML Alvarez","year":"2016","unstructured":"Alvarez, M. L. et al. Correction: role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLoS ONE 11, e0168353 (2016).","journal-title":"PLoS ONE"},{"key":"1755_CR406","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.gendis.2022.05.037","volume":"10","author":"F Wu","year":"2023","unstructured":"Wu, F. et al. Regulation mechanism and pathogenic role of lncRNA plasmacytoma variant translocation 1 (PVT1) in human diseases. Genes Dis. 10, 901\u2013914 (2023).","journal-title":"Genes Dis."},{"key":"1755_CR407","doi-asserted-by":"publisher","first-page":"1068408","DOI":"10.3389\/fgene.2022.1068408","volume":"13","author":"SS Bhadsavle","year":"2022","unstructured":"Bhadsavle, S. S. & Golding, M. C. Paternal epigenetic influences on placental health and their impacts on offspring development and disease. Front. Genet. 13, 1068408 (2022).","journal-title":"Front. Genet."},{"key":"1755_CR408","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3390\/molecules26082179","volume":"26","author":"WH Talib","year":"2021","unstructured":"Talib, W. H. et al. Diabetes and cancer: metabolic association, therapeutic challenges, and the role of natural products. Molecules 26, 2179 (2021).","journal-title":"Molecules"},{"key":"1755_CR409","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.biopha.2018.07.157","volume":"107","author":"B Giri","year":"2018","unstructured":"Giri, B. et al. Chronic hyperglycemia mediated physiological alteration and metabolic distortion leads to organ dysfunction, infection, cancer progression and other pathophysiological consequences: an update on glucose toxicity. Biomed. Pharmacother. 107, 306\u2013328 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"1755_CR410","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1515\/hmbci-2016-0022","volume":"26","author":"C Lee","year":"2016","unstructured":"Lee, C., An, D. & Park, J. Hyperglycemic memory in metabolism and cancer. Horm. Mol. Biol. Clin. Investig. 26, 77\u201385 (2016).","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"1755_CR411","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.yexcr.2014.03.019","volume":"324","author":"C Gupta","year":"2014","unstructured":"Gupta, C., Kaur, J. & Tikoo, K. Regulation of MDA-MB-231 cell proliferation by GSK-3\u03b2 involves epigenetic modifications under high glucose conditions. Exp. Cell Res. 324, 75\u201383 (2014).","journal-title":"Exp. Cell Res."},{"key":"1755_CR412","doi-asserted-by":"publisher","first-page":"21058","DOI":"10.1073\/pnas.1214400109","volume":"109","author":"J Park","year":"2012","unstructured":"Park, J. et al. Neuregulin 1-HER axis as a key mediator of hyperglycemic memory effects in breast cancer. Proc. Natl Acad. Sci. USA 109, 21058\u201321063 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR413","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36179-8","volume":"14","author":"C Lee","year":"2023","unstructured":"Lee, C. et al. Epigenetic regulation of Neuregulin 1 promotes breast cancer progression associated to hyperglycemia. Nat. Commun. 14, 439 (2023).","journal-title":"Nat. Commun."},{"key":"1755_CR414","doi-asserted-by":"publisher","first-page":"629666","DOI":"10.3389\/fonc.2021.629666","volume":"11","author":"S Dong","year":"2021","unstructured":"Dong, S., Wang, Z., Shen, K. & Chen, X. Metabolic syndrome and breast cancer: prevalence, treatment response, and prognosis. Front Oncol. 11, 629666 (2021).","journal-title":"Front Oncol."},{"key":"1755_CR415","doi-asserted-by":"publisher","first-page":"e10141","DOI":"10.15252\/msb.202010141","volume":"17","author":"K Radic Shechter","year":"2021","unstructured":"Radic Shechter, K. et al. Metabolic memory underlying minimal residual disease in breast cancer. Mol. Syst. Biol. 17, e10141 (2021).","journal-title":"Mol. Syst. Biol."},{"key":"1755_CR416","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1158\/1078-0432.CCR-11-0817","volume":"18","author":"B Pan","year":"2012","unstructured":"Pan, B. et al. HDL of patients with type 2 diabetes mellitus elevates the capability of promoting breast cancer metastasis. Clin. Cancer Res. 18, 1246\u20131256 (2012).","journal-title":"Clin. Cancer Res."},{"key":"1755_CR417","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1007\/s00204-023-03539-8","volume":"97","author":"TY Chang","year":"2023","unstructured":"Chang, T. Y. et al. N\u03b5-(1-Carboxymethyl)-L-lysine, an advanced glycation end product, exerts malignancy on chondrosarcoma via the activation of cancer stemness. Arch. Toxicol. 97, 2231\u20132244 (2023).","journal-title":"Arch. Toxicol."},{"key":"1755_CR418","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12933-014-0168-x","volume":"14","author":"R Fontes-Carvalho","year":"2015","unstructured":"Fontes-Carvalho, R. et al. Diastolic dysfunction in the diabetic continuum: association with insulin resistance, metabolic syndrome and type 2 diabetes. Cardiovasc. Diabetol. 14, 4 (2015).","journal-title":"Cardiovasc. Diabetol."},{"key":"1755_CR419","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13578-022-00927-y","volume":"12","author":"C Cai","year":"2022","unstructured":"Cai, C. et al. DNA methylation in diabetic retinopathy: pathogenetic role and potential therapeutic targets. Cell Biosci. 12, 186 (2022).","journal-title":"Cell Biosci."},{"key":"1755_CR420","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fendo.2019.00001","volume":"10","author":"T Willmer","year":"2019","unstructured":"Willmer, T., Johnson, R., Louw, J. & Pheiffer, C. Corrigendum: blood-based DNA methylation biomarkers for type 2 diabetes: potential for clinical applications. Front. Endocrinol. 10, 1 (2019).","journal-title":"Front. Endocrinol."},{"key":"1755_CR421","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.gendis.2021.12.010","volume":"9","author":"SJ Baek","year":"2022","unstructured":"Baek, S. J. et al. Genome-wide DNA methylation profiling reveals candidate biomarkers and probable molecular mechanism of metabolic syndrome. Genes Dis. 9, 833\u2013836 (2022).","journal-title":"Genes Dis."},{"key":"1755_CR422","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/hmg\/ddq513","volume":"20","author":"D Aran","year":"2011","unstructured":"Aran, D., Toperoff, G., Rosenberg, M. & Hellman, A. Replication timing-related and gene body-specific methylation of active human genes. Hum. Mol. Genet. 20, 670\u2013680 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"1755_CR423","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/hmg\/ddr472","volume":"21","author":"G Toperoff","year":"2012","unstructured":"Toperoff, G. et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum. Mol. Genet. 21, 371\u2013383 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"1755_CR424","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-015-0069-1","volume":"7","author":"G Toperoff","year":"2015","unstructured":"Toperoff, G. et al. Premature aging of leukocyte DNA methylation is associated with type 2 diabetes prevalence. Clin. Epigenetics 7, 35 (2015).","journal-title":"Clin. Epigenetics"},{"key":"1755_CR425","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S2213-8587(15)00127-8","volume":"3","author":"JC Chambers","year":"2015","unstructured":"Chambers, J. C. et al. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 3, 526\u2013534 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1755_CR426","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s10038-020-00848-z","volume":"66","author":"R Qie","year":"2021","unstructured":"Qie, R. et al. Association of ABCG1 gene methylation and its dynamic change status with incident type 2 diabetes mellitus: the Rural Chinese Cohort Study. J. Hum. Genet. 66, 347\u2013357 (2021).","journal-title":"J. Hum. Genet."},{"key":"1755_CR427","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1167\/tvst.8.6.43","volume":"8","author":"AJ Duraisamy","year":"2019","unstructured":"Duraisamy, A. J. et al. Epigenetic modifications in peripheral blood as potential noninvasive biomarker of diabetic retinopathy. Transl. Vis. Sci. Technol. 8, 43 (2019).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"1755_CR428","doi-asserted-by":"publisher","first-page":"624","DOI":"10.3390\/cells9030624","volume":"9","author":"V Const\u00e2ncio","year":"2020","unstructured":"Const\u00e2ncio, V., Nunes, S. P., Henrique, R. & Jer\u00f3nimo, C. DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types. Cells 9, 624 (2020).","journal-title":"Cells"},{"key":"1755_CR429","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1210\/endrev\/bnab021","volume":"42","author":"SE Kahn","year":"2021","unstructured":"Kahn, S. E. et al. The \u03b2 cell in diabetes: integrating biomarkers with functional measures. Endocr. Rev. 42, 528\u2013583 (2021).","journal-title":"Endocr. Rev."},{"key":"1755_CR430","doi-asserted-by":"publisher","first-page":"e6953","DOI":"10.1371\/journal.pone.0006953","volume":"4","author":"A Kuroda","year":"2009","unstructured":"Kuroda, A. et al. Insulin gene expression is regulated by DNA methylation. PLoS ONE 4, e6953 (2009).","journal-title":"PLoS ONE"},{"key":"1755_CR431","doi-asserted-by":"publisher","first-page":"19018","DOI":"10.1073\/pnas.1111008108","volume":"108","author":"EM Akirav","year":"2011","unstructured":"Akirav, E. M. et al. Detection of \u03b2 cell death in diabetes using differentially methylated circulating DNA. Proc. Natl Acad. Sci. USA 108, 19018\u201319023 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR432","doi-asserted-by":"publisher","first-page":"e47942","DOI":"10.1371\/journal.pone.0047942","volume":"7","author":"MI Husseiny","year":"2012","unstructured":"Husseiny, M. I. et al. Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes. PLoS ONE 7, e47942 (2012).","journal-title":"PLoS ONE"},{"key":"1755_CR433","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.1210\/en.2013-1223","volume":"154","author":"MM Fisher","year":"2013","unstructured":"Fisher, M. M. et al. Detection of islet \u03b2-cell death in vivo by multiplex PCR analysis of differentially methylated DNA. Endocrinology 154, 3476\u20133481 (2013).","journal-title":"Endocrinology"},{"key":"1755_CR434","doi-asserted-by":"publisher","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","volume":"113","author":"R Lehmann-Werman","year":"2016","unstructured":"Lehmann-Werman, R. et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc. Natl Acad. Sci. USA 113, E1826\u2013E1834 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1755_CR435","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.2337\/db12-1207","volume":"62","author":"J Lebastchi","year":"2013","unstructured":"Lebastchi, J. et al. Immune therapy and \u03b2-cell death in type 1 diabetes. Diabetes 62, 1676\u20131680 (2013).","journal-title":"Diabetes"},{"key":"1755_CR436","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1210\/en.2014-1150","volume":"155","author":"S Usmani-Brown","year":"2014","unstructured":"Usmani-Brown, S. et al. Analysis of \u03b2-cell death in type 1 diabetes by droplet digital PCR. Endocrinology 155, 3694\u20133698 (2014).","journal-title":"Endocrinology"},{"key":"1755_CR437","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-017-0343-5","volume":"9","author":"K Zhang","year":"2017","unstructured":"Zhang, K. et al. Circulating unmethylated insulin DNA as a potential non-invasive biomarker of beta cell death in type 1 Diabetes: a review and future prospect. Clin. Epigenetics 9, 44 (2017).","journal-title":"Clin. Epigenetics"},{"key":"1755_CR438","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/ajt.14054","volume":"17","author":"MD Bellin","year":"2017","unstructured":"Bellin, M. D. et al. Unmethylated insulin DNA is elevated after total pancreatectomy with islet autotransplantation: assessment of a novel beta cell marker. Am. J. Transplant. 17, 1112\u20131118 (2017).","journal-title":"Am. J. Transplant."},{"key":"1755_CR439","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2337\/db18-1193","volume":"68","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. A peripheral blood DNA methylation signature of hepatic fat reveals a potential causal pathway for nonalcoholic fatty liver disease. Diabetes 68, 1073\u20131083 (2019).","journal-title":"Diabetes"},{"key":"1755_CR440","doi-asserted-by":"publisher","first-page":"e96685","DOI":"10.1172\/jci.insight.96685","volume":"3","author":"R Loomba","year":"2018","unstructured":"Loomba, R. et al. DNA methylation signatures reflect aging in patients with nonalcoholic steatohepatitis. JCI Insight 3, e96685 (2018).","journal-title":"JCI Insight"},{"key":"1755_CR441","doi-asserted-by":"publisher","first-page":"12843","DOI":"10.3390\/ijms232112843","volume":"23","author":"MA Angelescu","year":"2022","unstructured":"Angelescu, M. A. et al. miRNAs as biomarkers in diabetes: moving towards precision medicine. Int. J. Mol. Sci. 23, 12843 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR442","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.gendis.2022.05.022","volume":"10","author":"A Dandare","year":"2023","unstructured":"Dandare, A., Khan, M. J., Naeem, A. & Liaquat, A. Clinical relevance of circulating non-coding RNAs in metabolic diseases: Emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome. Genes Dis. 10, 2393\u20132413 (2023).","journal-title":"Genes Dis."},{"key":"1755_CR443","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0194-y","volume":"50","author":"R Jim\u00e9nez-Lucena","year":"2018","unstructured":"Jim\u00e9nez-Lucena, R. et al. A plasma circulating miRNAs profile predicts type 2 diabetes mellitus and prediabetes: from the CORDIOPREV study. Exp. Mol. Med. 50, 1\u201312 (2018).","journal-title":"Exp. Mol. Med."},{"key":"1755_CR444","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.2337\/db17-0526","volume":"67","author":"KA Lo","year":"2018","unstructured":"Lo, K. A. et al. Adipocyte long-noncoding RNA transcriptome analysis of obese mice identified Lnc-Leptin, which regulates leptin. Diabetes 67, 1045\u20131056 (2018).","journal-title":"Diabetes"},{"key":"1755_CR445","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/ijms23031341","volume":"23","author":"AM Mahmoud","year":"2022","unstructured":"Mahmoud, A. M. An overview of epigenetics in obesity: the role of lifestyle and therapeutic interventions. Int. J. Mol. Sci. 23, 1341 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR446","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrendo.2016.87","volume":"12","author":"R Barr\u00e8s","year":"2016","unstructured":"Barr\u00e8s, R. & Zierath, J. R. The role of diet and exercise in the transgenerational epigenetic landscape of T2DM. Nat. Rev. Endocrinol. 12, 441\u2013451 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1755_CR447","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0707-0","volume":"11","author":"E Hibler","year":"2019","unstructured":"Hibler, E., Huang, L., Andrade, J. & Spring, B. Impact of a diet and activity health promotion intervention on regional patterns of DNA methylation. Clin. Epigenetics 11, 133 (2019).","journal-title":"Clin. Epigenetics"},{"key":"1755_CR448","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0659-4","volume":"11","author":"S Li","year":"2019","unstructured":"Li, S., Chen, M., Li, Y. & Tollefsbol, T. O. Prenatal epigenetics diets play protective roles against environmental pollution. Clin. Epigenetics 11, 82 (2019).","journal-title":"Clin. Epigenetics"},{"key":"1755_CR449","doi-asserted-by":"publisher","first-page":"108646","DOI":"10.1016\/j.foodres.2019.108646","volume":"125","author":"L Silva","year":"2019","unstructured":"Silva, L. et al. Bioactive food compounds, epigenetics and chronic disease prevention: focus on early-life interventions with polyphenols. Food Res. Int. 125, 108646 (2019).","journal-title":"Food Res. Int."},{"key":"1755_CR450","doi-asserted-by":"publisher","first-page":"846","DOI":"10.4103\/1673-5374.382232","volume":"19","author":"WO Castillo-Ordo\u00f1ez","year":"2024","unstructured":"Castillo-Ordo\u00f1ez, W. O., Cajas-Salazar, N. & Velasco-Reyes, M. A. Genetic and epigenetic targets of natural dietary compounds as anti-Alzheimer\u2019s agents. Neural Regen. Res. 19, 846\u2013854 (2024).","journal-title":"Neural Regen. Res."},{"key":"1755_CR451","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.cell.2014.10.029","volume":"159","author":"JA Hawley","year":"2014","unstructured":"Hawley, J. A., Hargreaves, M., Joyner, M. J. & Zierath, J. R. Integrative biology of exercise. Cell 159, 738\u2013749 (2014).","journal-title":"Cell"},{"key":"1755_CR452","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.metabol.2015.09.013","volume":"64","author":"JM Dos Santos","year":"2015","unstructured":"Dos Santos, J. M., Moreli, M. L., Tewari, S. & Benite-Ribeiro, S. A. The effect of exercise on skeletal muscle glucose uptake in type 2 diabetes: an epigenetic perspective. Metabolism 64, 1619\u20131628 (2015).","journal-title":"Metabolism"},{"key":"1755_CR453","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cmet.2012.01.001","volume":"15","author":"R Barr\u00e8s","year":"2012","unstructured":"Barr\u00e8s, R. et al. Acute exercise remodels promoter methylation in human skeletal muscle. Cell Metab. 15, 405\u2013411 (2012).","journal-title":"Cell Metab."},{"key":"1755_CR454","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.mehy.2014.03.018","volume":"82","author":"JM Santos","year":"2014","unstructured":"Santos, J. M., Tewari, S. & Benite-Ribeiro, S. A. The effect of exercise on epigenetic modifications of PGC1: the impact on type 2 diabetes. Med. Hypotheses 82, 748\u2013753 (2014).","journal-title":"Med. Hypotheses"},{"key":"1755_CR455","doi-asserted-by":"publisher","first-page":"e1003572","DOI":"10.1371\/journal.pgen.1003572","volume":"9","author":"T R\u00f6nn","year":"2013","unstructured":"R\u00f6nn, T. et al. A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue. PLoS Genet. 9, e1003572 (2013).","journal-title":"PLoS Genet."},{"key":"1755_CR456","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1152\/physiolgenomics.00024.2014","volume":"46","author":"DS Rowlands","year":"2014","unstructured":"Rowlands, D. S. et al. Multi-omic integrated networks connect DNA methylation and miRNA with skeletal muscle plasticity to chronic exercise in Type 2 diabetic obesity. Physiol. Genomics. 46, 747\u2013765 (2014).","journal-title":"Physiol. Genomics."},{"key":"1755_CR457","doi-asserted-by":"publisher","first-page":"29","DOI":"10.31083\/j.rcm2301029","volume":"23","author":"AC Improta-Caria","year":"2022","unstructured":"Improta-Caria, A. C. et al. MicroRNAs in type 2 diabetes mellitus: potential role of physical exercise. Rev. Cardiovasc. Med. 23, 29 (2022).","journal-title":"Rev. Cardiovasc. Med."},{"key":"1755_CR458","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000517849","volume":"15","author":"A Silveira","year":"2022","unstructured":"Silveira, A. et al. MicroRNAs in obesity-associated disorders: the role of exercise training. Obes. Facts 15, 105\u2013117 (2022).","journal-title":"Obes. Facts"},{"key":"1755_CR459","doi-asserted-by":"publisher","first-page":"120723","DOI":"10.1016\/j.lfs.2022.120723","volume":"304","author":"JAC Dos Santos","year":"2022","unstructured":"Dos Santos, J. A. C. et al. Physical exercise and the functions of microRNAs. Life Sci. 304, 120723 (2022).","journal-title":"Life Sci."},{"key":"1755_CR460","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1210\/jc.2018-01820","volume":"104","author":"D Olioso","year":"2019","unstructured":"Olioso, D. et al. Effects of aerobic and resistance training on circulating micro-RNA expression profile in subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 104, 1119\u20131130 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1755_CR461","doi-asserted-by":"publisher","first-page":"e22839","DOI":"10.1371\/journal.pone.0022839","volume":"6","author":"DS Karolina","year":"2011","unstructured":"Karolina, D. S. et al. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS ONE 6, e22839 (2011).","journal-title":"PLoS ONE"},{"key":"1755_CR462","doi-asserted-by":"publisher","first-page":"H1629","DOI":"10.1152\/ajpheart.00941.2014","volume":"309","author":"RW Souza","year":"2015","unstructured":"Souza, R. W. et al. Regulation of cardiac microRNAs induced by aerobic exercise training during heart failure. Am. J. Physiol. Heart Circ. Physiol. 309, H1629\u2013H1641 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"1755_CR463","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/21623945.2020.1798632","volume":"9","author":"HA Fachim","year":"2020","unstructured":"Fachim, H. A. et al. Circulating microRNA changes in patients with impaired glucose regulation. Adipocyte 9, 443\u2013453 (2020).","journal-title":"Adipocyte"},{"key":"1755_CR464","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.diabres.2010.11.006","volume":"91","author":"LL Sun","year":"2011","unstructured":"Sun, L. L. et al. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Res. Clin. Pract. 91, 94\u2013100 (2011).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"1755_CR465","doi-asserted-by":"publisher","first-page":"100179","DOI":"10.1016\/j.jhepr.2020.100179","volume":"2","author":"Z Wang","year":"2020","unstructured":"Wang, Z. et al. Hepatic miR-192-3p reactivation alleviates steatosis by targeting glucocorticoid receptor. JHEP Rep. 2, 100179 (2020).","journal-title":"JHEP Rep."},{"key":"1755_CR466","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1752-8062.2011.00384.x","volume":"5","author":"S Radom-Aizik","year":"2012","unstructured":"Radom-Aizik, S. et al. Effects of exercise on microRNA expression in young males peripheral blood mononuclear cells. Clin. Transl. Sci. 5, 32\u201338 (2012).","journal-title":"Clin. Transl. Sci."},{"key":"1755_CR467","doi-asserted-by":"publisher","first-page":"E407","DOI":"10.1210\/jc.2014-2574","volume":"100","author":"M P\u00e1rrizas","year":"2015","unstructured":"P\u00e1rrizas, M. et al. Circulating miR-192 and miR-193b are markers of prediabetes and are modulated by an exercise intervention. J. Clin. Endocrinol. Metab. 100, E407\u2013E415 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1755_CR468","doi-asserted-by":"publisher","first-page":"108486","DOI":"10.1016\/j.jnutbio.2020.108486","volume":"86","author":"R Kiyama","year":"2020","unstructured":"Kiyama, R. Nutritional implications of ginger: chemistry, biological activities and signaling pathways. J. Nutr. Biochem. 86, 108486 (2020).","journal-title":"J. Nutr. Biochem."},{"key":"1755_CR469","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/mnfr.201200791","volume":"57","author":"MR Maradana","year":"2013","unstructured":"Maradana, M. R., Thomas, R. & O\u2019Sullivan, B. J. Targeted delivery of curcumin for treating type 2 diabetes. Mol. Nutr. Food Res. 57, 1550\u20131556 (2013).","journal-title":"Mol. Nutr. Food Res."},{"key":"1755_CR470","doi-asserted-by":"publisher","first-page":"E127","DOI":"10.1152\/ajpendo.00432.2009","volume":"298","author":"S Chen","year":"2010","unstructured":"Chen, S. et al. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 298, E127\u2013E137 (2010).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1755_CR471","doi-asserted-by":"publisher","first-page":"25869","DOI":"10.1074\/jbc.M112.375204","volume":"287","author":"CS Kadiyala","year":"2012","unstructured":"Kadiyala, C. S. et al. Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC). J. Biol. Chem. 287, 25869\u201325880 (2012).","journal-title":"J. Biol. Chem."},{"key":"1755_CR472","doi-asserted-by":"publisher","first-page":"153749","DOI":"10.1016\/j.phymed.2021.153749","volume":"92","author":"Y Yin","year":"2021","unstructured":"Yin, Y. et al. Astragaloside IV alleviates Schwann cell injury in diabetic peripheral neuropathy by regulating microRNA-155-mediated autophagy. Phytomedicine 92, 153749 (2021).","journal-title":"Phytomedicine"},{"key":"1755_CR473","doi-asserted-by":"publisher","first-page":"13762","DOI":"10.3390\/ijms241813762","volume":"24","author":"S Qin","year":"2023","unstructured":"Qin, S. et al. Could cyclosiversioside F serve as a dietary supplement to prevent obesity and relevant disorders? Int. J. Mol. Sci. 24, 13762 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR474","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1039\/C2FO30199G","volume":"4","author":"ER Gilbert","year":"2013","unstructured":"Gilbert, E. R. & Liu, D. Anti-diabetic functions of soy isoflavone genistein: mechanisms underlying its effects on pancreatic \u03b2-cell function. Food Funct. 4, 200\u2013212 (2013).","journal-title":"Food Funct."},{"key":"1755_CR475","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.3390\/molecules25235713","volume":"25","author":"SC Yang","year":"2020","unstructured":"Yang, S. C. et al. Bioactive agent discovery from the natural compounds for the treatment of type 2 diabetes rat model. Molecules 25, 5713 (2020).","journal-title":"Molecules"},{"key":"1755_CR476","doi-asserted-by":"publisher","first-page":"3996","DOI":"10.3390\/molecules28103996","volume":"28","author":"R Naz","year":"2023","unstructured":"Naz, R. et al. Food polyphenols and type II diabetes mellitus: pharmacology and mechanisms. Molecules 28, 3996 (2023).","journal-title":"Molecules"},{"key":"1755_CR477","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/biom9030099","volume":"9","author":"DJ Den Hartogh","year":"2019","unstructured":"Den Hartogh, D. J. & Tsiani, E. Antidiabetic properties of naringenin: a citrus fruit polyphenol. Biomolecules 9, 99 (2019).","journal-title":"Biomolecules"},{"key":"1755_CR478","doi-asserted-by":"publisher","first-page":"153454","DOI":"10.1016\/j.phymed.2020.153454","volume":"88","author":"SW Wang","year":"2021","unstructured":"Wang, S. W. et al. Inhibition of histone acetyltransferase by naringenin and hesperetin suppresses Txnip expression and protects pancreatic \u03b2 cells in diabetic mice. Phytomedicine 88, 153454 (2021).","journal-title":"Phytomedicine"},{"key":"1755_CR479","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/nu14010057","volume":"14","author":"S G\u00f3mez-Mart\u00ednez","year":"2021","unstructured":"G\u00f3mez-Mart\u00ednez, S. et al. Moringa oleifera leaf supplementation as a glycemic control strategy in subjects with prediabetes. Nutrients 14, 57 (2021).","journal-title":"Nutrients"},{"key":"1755_CR480","doi-asserted-by":"publisher","first-page":"154434","DOI":"10.1016\/j.phymed.2022.154434","volume":"107","author":"J Yang","year":"2022","unstructured":"Yang, J. et al. Magnolol effectively ameliorates diabetic peripheral neuropathy in mice. Phytomedicine 107, 154434 (2022).","journal-title":"Phytomedicine"},{"key":"1755_CR481","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/nu9111201","volume":"9","author":"GFS Fernandes","year":"2017","unstructured":"Fernandes, G. F. S. et al. Epigenetic regulatory mechanisms induced by resveratrol. Nutrients 9, 1201 (2017).","journal-title":"Nutrients"},{"key":"1755_CR482","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.3390\/molecules25143287","volume":"25","author":"B Karaman Mayack","year":"2020","unstructured":"Karaman Mayack, B., Sippl, W. & Ntie-Kang, F. Natural products as modulators of sirtuins. Molecules 25, 3287 (2020).","journal-title":"Molecules"},{"key":"1755_CR483","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2015.01.002","volume":"21","author":"MG Novelle","year":"2015","unstructured":"Novelle, M. G. et al. Resveratrol supplementation: Where are we now and where should we go? Ageing Res. Rev. 21, 1\u201315 (2015).","journal-title":"Ageing Res. Rev."},{"key":"1755_CR484","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3945\/ajcn.113.082024","volume":"99","author":"K Liu","year":"2014","unstructured":"Liu, K., Zhou, R., Wang, B. & Mi, M. T. Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. Am. J. Clin. Nutr. 99, 1510\u20131519 (2014).","journal-title":"Am. J. Clin. Nutr."},{"key":"1755_CR485","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2174\/138920101606150407113644","volume":"16","author":"S Costantino","year":"2015","unstructured":"Costantino, S., Paneni, F. & Cosentino, F. Targeting chromatin remodeling to prevent cardiovascular disease in diabetes. Curr. Pharm. Biotechnol. 16, 531\u2013543 (2015).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"1755_CR486","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.drudis.2015.12.001","volume":"21","author":"AO Arguelles","year":"2016","unstructured":"Arguelles, A. O., Meruvu, S., Bowman, J. D. & Choudhury, M. Are epigenetic drugs for diabetes and obesity at our door step? Drug Discov. Today 21, 499\u2013509 (2016).","journal-title":"Drug Discov. Today"},{"key":"1755_CR487","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0222-5","volume":"8","author":"L Altucci","year":"2016","unstructured":"Altucci, L. & Rots, M. G. Epigenetic drugs: from chemistry via biology to medicine and back. Clin. Epigenetics 8, 56 (2016).","journal-title":"Clin. Epigenetics"},{"key":"1755_CR488","doi-asserted-by":"publisher","first-page":"e87748","DOI":"10.1172\/jci.insight.87748","volume":"1","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity. JCI Insight 1, e87748 (2016).","journal-title":"JCI Insight"},{"key":"1755_CR489","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/jbt.21807","volume":"30","author":"S Khan","year":"2016","unstructured":"Khan, S. & Jena, G. Valproic acid improves glucose homeostasis by increasing beta-cell proliferation, function, and reducing its apoptosis through hdac inhibition in juvenile diabetic rat. J. Biochem. Mol. Toxicol. 30, 438\u2013446 (2016).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"1755_CR490","doi-asserted-by":"publisher","first-page":"28783","DOI":"10.1074\/jbc.M113.489732","volume":"288","author":"A Dudakovic","year":"2013","unstructured":"Dudakovic, A. et al. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation. J. Biol. Chem. 288, 28783\u201328791 (2013).","journal-title":"J. Biol. Chem."},{"key":"1755_CR491","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.tig.2020.03.003","volume":"36","author":"A Bayoumi","year":"2020","unstructured":"Bayoumi, A., Gr\u00f8nb\u00e6k, H., George, J. & Eslam, M. The epigenetic drug discovery landscape for metabolic-associated fatty liver disease. Trends Genet. 36, 429\u2013441 (2020).","journal-title":"Trends Genet."},{"key":"1755_CR492","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1172\/JCI69739","volume":"124","author":"SC Navada","year":"2014","unstructured":"Navada, S. C., Steinmann, J., L\u00fcbbert, M. & Silverman, L. R. Clinical development of demethylating agents in hematology. J. Clin. Invest. 124, 40\u201346 (2014).","journal-title":"J. Clin. Invest."},{"key":"1755_CR493","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.3390\/ijms24054778","volume":"24","author":"J Ueda","year":"2023","unstructured":"Ueda, J., Yamazaki, T. & Funakoshi, H. Toward the development of epigenome editing-based therapeutics: potentials and challenges. Int. J. Mol. Sci. 24, 4778 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1755_CR494","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11892-019-1193-7","volume":"19","author":"S Negi","year":"2019","unstructured":"Negi, S., Rutman, A. K. & Paraskevas, S. Extracellular vesicles in type 1 diabetes: messengers and regulators. Curr. Diabetes Rep. 19, 69 (2019).","journal-title":"Curr. Diabetes Rep."},{"key":"1755_CR495","doi-asserted-by":"publisher","first-page":"7268","DOI":"10.1111\/jcmm.14555","volume":"23","author":"J Shi","year":"2019","unstructured":"Shi, J. et al. Exosomes from miR-20b-3p-overexpressing stromal cells ameliorate calcium oxalate deposition in rat kidney. J. Cell Mol. Med. 23, 7268\u20137278 (2019).","journal-title":"J. Cell Mol. Med."},{"key":"1755_CR496","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/iub.2267","volume":"72","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Elevated microRNA-20b-3p and reduced thioredoxin-interacting protein ameliorate diabetic retinopathy progression by suppressing the NLRP3 inflammasomes. IUBMB Life 72, 1433\u20131448 (2020).","journal-title":"IUBMB Life"},{"key":"1755_CR497","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-02222-5","volume":"21","author":"J Li","year":"2023","unstructured":"Li, J. et al. Plasma exosomes improve peripheral neuropathy via miR-20b-3p\/Stat3 in type I diabetic rats. J. Nanobiotechnol. 21, 447 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"1755_CR498","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrc1799","volume":"6","author":"SB Baylin","year":"2006","unstructured":"Baylin, S. B. & Ohm, J. E. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer 6, 107\u2013116 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"1755_CR499","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00862-0","volume":"12","author":"T Zhang","year":"2020","unstructured":"Zhang, T. et al. Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor. Clin. Epigenetics 12, 72 (2020).","journal-title":"Clin. Epigenetics"},{"key":"1755_CR500","doi-asserted-by":"publisher","first-page":"175590","DOI":"10.1016\/j.ejphar.2023.175590","volume":"944","author":"LL Marzochi","year":"2023","unstructured":"Marzochi, L. L. et al. Use of histone methyltransferase inhibitors in cancer treatment: a systematic review. Eur. J. Pharmacol. 944, 175590 (2023).","journal-title":"Eur. J. Pharmacol."},{"key":"1755_CR501","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/dc21-2438","volume":"45","author":"AM Jacobson","year":"2022","unstructured":"Jacobson, A. M. et al. Brain structure among middle-aged and older adults with long-standing type 1 diabetes in the DCCT\/EDIC study. Diabetes Care 45, 1779\u20131787 (2022).","journal-title":"Diabetes Care"},{"key":"1755_CR502","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2337\/dc21-1816","volume":"45","author":"EJ Boyko","year":"2022","unstructured":"Boyko, E. J. et al. Risk of foot ulcer and lower-extremity amputation among participants in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study. Diabetes Care 45, 357\u2013364 (2022).","journal-title":"Diabetes Care"},{"key":"1755_CR503","doi-asserted-by":"crossref","unstructured":"Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT\/EDIC Study 30-Year Follow-up. Diabetes Care 39, 686\u2013693, (2016).","DOI":"10.2337\/dc15-1990"},{"key":"1755_CR504","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12933-015-0266-4","volume":"14","author":"VM Monnier","year":"2015","unstructured":"Monnier, V. M. et al. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes. Cardiovasc. Diabetol. 14, 118 (2015).","journal-title":"Cardiovasc. Diabetol."},{"key":"1755_CR505","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1001\/archopht.126.12.1707","volume":"126","author":"NH White","year":"2008","unstructured":"White, N. H. et al. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial. Arch. Ophthalmol. 126, 1707\u20131715 (2008).","journal-title":"Arch. Ophthalmol."},{"key":"1755_CR506","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2020.3308","volume":"323","author":"KK Ray","year":"2020","unstructured":"Ray, K. K. et al. Effect of apabetalone added to standard therapy on major adverse cardiovascular events in patients with recent acute coronary syndrome and type 2 diabetes: a randomized clinical trial. J. Am. Med. Assoc. 323, 1565\u20131573 (2020).","journal-title":"J. Am. Med. Assoc."},{"key":"1755_CR507","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2215\/CJN.16751020","volume":"16","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh, K. et al. Effect of apabetalone on cardiovascular events in diabetes, CKD, and recent acute coronary syndrome: results from the BETonMACE randomized controlled trial. Clin. J. Am. Soc. Nephrol. 16, 705\u2013716 (2021).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1755_CR508","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.3233\/JAD-210570","volume":"83","author":"J Cummings","year":"2021","unstructured":"Cummings, J. et al. Cognitive effects of the BET protein inhibitor apabetalone: a prespecified montreal cognitive assessment analysis nested in the BETonMACE randomized controlled trial. J. Alzheimers Dis. 83, 1703\u20131715 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"1755_CR509","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00592-017-1097-4","volume":"55","author":"S Bo","year":"2018","unstructured":"Bo, S. et al. Impact of sirtuin-1 expression on H3K56 acetylation and oxidative stress: a double-blind randomized controlled trial with resveratrol supplementation. Acta Diabetol. 55, 331\u2013340 (2018).","journal-title":"Acta Diabetol."},{"key":"1755_CR510","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s13105-017-0552-6","volume":"73","author":"A Arp\u00f3n","year":"2016","unstructured":"Arp\u00f3n, A. et al. Adherence to Mediterranean diet is associated with methylation changes in inflammation-related genes in peripheral blood cells. J. Physiol. Biochem. 73, 445\u2013455 (2016).","journal-title":"J. Physiol. Biochem."},{"key":"1755_CR511","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu10010015","volume":"10","author":"A Arp\u00f3n","year":"2017","unstructured":"Arp\u00f3n, A. et al. Impact of consuming extra-virgin olive oil or nuts within a mediterranean diet on dna methylation in peripheral white blood cells within the predimed-navarra randomized controlled trial: a role for dietary lipids. Nutrients 10, 15 (2017).","journal-title":"Nutrients"},{"key":"1755_CR512","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1111\/dom.13333","volume":"20","author":"D Sun","year":"2018","unstructured":"Sun, D. et al. Genetic, epigenetic and transcriptional variations at NFATC2IP locus with weight loss in response to diet interventions: The POUNDS Lost Trial. Diabetes Obes. Metab. 20, 2298\u20132303 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"1755_CR513","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00592-019-01442-2","volume":"57","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. The clinical significance of long non-coding RNA ANRIL level in diabetic retinopathy. Acta Diabetol. 57, 409\u2013418 (2020).","journal-title":"Acta Diabetol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01755-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01755-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01755-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T01:02:34Z","timestamp":1709082154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-024-01755-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,28]]},"references-count":513,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1755"],"URL":"https:\/\/doi.org\/10.1038\/s41392-024-01755-x","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,28]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38"}}